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Abstract
Drosophila melanogaster E93 is an early ecdysone response gene that encodes a
pipsqueak domain transcription factor. E93 is induced by ecdysone at the end of larval
development, and directs the death and elimination of several larval tissues during
metamorphosis. Although E93 has been considered a dedicated regulator of larval cell
death, I have found that E93 is also widely expressed in imaginal tissues during
metamorphosis, where it is required for the proper patterning of many adult
structures. Our working hypothesis is that E93 functions in imaginal tissues as a
metamorphosis-specific cofactor that determines the pupa-specific action of numerous
other transcription factors involved in imaginal patterning. For my thesis work, I focused
on a single E93-dependent patterning process, the induction of bracts by bristle cells in
the pupal leg. This induction is known to be mediated by EGFR signaling. My studies
position E93 downstream of the transcription factor Pointed in the EGFR pathway, and
upstream of the bract target gene Distal-less, consistent with the view that E93 functions
to control target gene specificity of EGFR signaling during metamorphosis.

I also

present the results of experiments to dissect functional domains within the E93 protein
and to determine whether alternate products of E93 execute the cell death and imaginal
patterning functions of E93.

Chapter II-V will present these works in detail and Chapter VI will discuss future
directions of this interesting project.
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Chapter I : Introduction and background
In this chapter, I first present background information on ecdysone signaling and
imaginal patterning during metamorphosis. I then introduce the main character of my
research: E93, a gene that appears to lie at the intersection of these two processes. I end
with our hypothesis that E93 functions as a metamorphosis-specific cofactor for many
transcription factors involved in imaginal patterning.

Ecdysone signaling
Ecdysone and the ecdysone receptor
Ecdysone is a steroid hormone that triggers major developmental transitions in
Drosophila and induces different gene responses in a stage specific and tissue specific
manner (Fig. I-1). Ecdysone is synthesized in the prothoracic gland, and released into the
haemolymph. The first ecdysone pulse occurs during embryogenesis, and may play some
role in cuticle deposition and morphogenesis (Chavez et al. 2000). Ecdysone pulses
during the first and second instars occur in combination with a high level of juvenile
hormone, and trigger the two larval molts (Dubrovsky et al. 2000; Zhou and Riddiford
2001). As the level of juvenile hormone goes down at the end of the 3rd instar, a sharp
increase of ecdysone drives the larva into pupariation and initiates metamorphosis.
During metamorphosis, most larval tissues are eliminated, whereas imaginal tissues
(future adult tissues) survive and differentiate into appropriate adult structures (Robertson
1936).
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The ecdysone receptor is a heterodimer of the ecdysteroid receptor (EcR) and
Ultraspiracle (Usp), the Drosophila homologue of the retinoid X receptor (Yao et al.
1992; Thomas et al. 1993). Both EcR and Usp are members of the nuclear receptor
superfamily (Mangelsdorf et al. 1995). EcR and Usp heterodimers bind ecdysone and the
complex then interacts with ecdysone response elements (EcRE) in target genes (Cherbas
et al. 1991; Yao et al. 1993). The EcR/Usp/ecdysone complex activates transcription of
some targets, but represses others (Tsai et al. 1999; Schubiger et al. 2005). The EcR has
three isoforms in Drosophila: EcR-A, EcR-B1, and EcR-B2 (Talbot et al. 1993). These
isoforms are expressed with different spatial and temporal patterns, and induce different
transcriptional activities (Talbot et al. 1993; Truman et al. 1994; Cherbas et al. 2003).
Thus, a variety of cellular responses have already been generated at the top of the
ecdysone signaling hierarchy.
Metamorphosis
Pupariation

Hatching
1st Molt

Eclosion

2nd Molt

20-H Ecdysone
Juvenile Hormone

0

24

48

72

96

0

12

24

48

72

96

Hours

Figure I-1: The hormonal regulation of the life cycle of Drosophila melanogaster
Blue line represents ecdysone. Green line represents juvenile hormone. X axis represents
development time in hours. It starts from the embryo and re-zeros at pupariation.
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Ecdysone response genes
The next components of the ecdysone signaling hierarchy are ecdysone response genes.
At the end of the third instar, the EcR/Usp/ecdysone complex induces a cascade of
ecdysone response genes. Many of these genes were identified as puffs in late larval
polytene chromosomes (Ashburner et al. 1974; Ashburner and Richards 1976). Among
these puff genes, a half dozen are called Early Puff Genes, which include the BroadComplex (BR-C), E74, E75, E63-1, E23 and E93 (Fig. I-2, Ashburner et al. 1974;
Ashburner and Richards 1976; Thummel 2002). The protein products of these Early Puff
Genes work as transcription factors to induce more than 100 Late Puff Genes and to
repress their own expression. The Late Puff Genes are divided into early-late genes (e.g.
DHR3, E78, and E62E) and late-late genes (e.g. 22C, 63E, 71E, 82F). The early-late
genes require ecdysone/receptor complex for expression, whereas the late-late genes are
repressed in the presence of ecdysone/receptor complex and hence are not induced until
after the ecdysone pulse ceases. The protein products of the Late Puff Genes function as
effectors to regulate specific responses in different tissues. The second pulse of ecdysone
around 10hr AP induces the Early Puff Genes and Late Puff Genes again (Ashburner et al.
1974; Ashburner and Richards 1976; Thummel 1996; Thummel 2002).

The best characterized ecdysone response genes are the early genes BR-C and E74, which
have a widespread impact in both larval and imaginal tissues (Kiss et al. 1988; Fletcher et
al. 1995). The BR-C is further divided into three complementation groups: br, rbp and
2BC (Belyaeva et al. 1980; Kiss et al. 1988). Each complementation unit encodes specific
protein isoforms and its mutant alleles cause specific defects. For example, br mutants
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fail in imaginal disc eversion, rbp mutants fail to undergo salivary gland histolysis, and
2Bc mutants are defective in imaginal disc fusion (Kiss et al. 1988; Emery et al. 1994).
Ecdyson
EcR/Us

EcR/Usp/Ecdysone
active complex

Early puff genes
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Pupariation
Ecdysone
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Late puff genes

-18
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0
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36

42
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Figure I-2: The Ashburner model for the gene regulation by ecdysone during the
metamorphosis
Ecdysone binds to its receptor to form an EcR/Usp/Ecdysone active Complex, which
induces Early Puff Genes and inhibits Late Puff Genes. The protein products of Early
Puff genes induce Late-Puff genes and inhibit their own expression. The second pulse of
ecdysone around 10hr AP induces Early Puff Genes and Late Puff Genes again.

Imaginal patterning
Imaginal patterning and larval remodeling during metamorphosis
Most work on the role of ecdysone signaling during metamorphosis has focused on early
events after pupariation, including the death of larval tissues (such as the larval midgut
4

and salivary gland), and the evagination of the imaginal discs.

These events are

controlled by the ecdysone peaks that initiate pupariation and that drive the prepupal to
pupal molt. Relatively little attention has been devoted to the subsequent strong and very
broad ecdysone peak that occurs during mid-pupal development.

Many different

imaginal patterning events take place at this time, and some of these events have been
shown to require ecdysone signaling. However, the ecdysone response genes responsible
for executing these effects have not been identified. The work presented in this thesis
indicates that the early response gene E93 is an important regulator of many of these
pupal patterning processes. Here I review the imaginal patterning processes known to
take place in mid-pupal development. These processes are of two types: the development
of structures derived from imaginal discs and histoblasts, and the generation of adult
structures by the remodeling of pre-existing larval structures.

Patterning of imaginal discs and histoblasts during metamorphosis.
A common misconception is that the patterning of imaginal discs is essentially complete
by the end of larval life, and that the role of ecdysone is simply to induce the
morphogenesis and final differentiation of adult structures. In fact, cell fate decisions
involved in the patterning of imaginal structures continue throughout most of pupal
development. For example, in eye development the patterning of 2̊ and 3˚ pigment cells
and the programmed cell death of excess lattice cells occurs between 24-48hr After
Pupariation (AP) (Freeman 1996; Brachmann and Cagan 2003).

In the antenna,

chemosensory sensilla are patterned in the mid pupal period (Sen et al. 2003) and
outgrowth of the aristal plume and apoptosis of central core cells begins at about 30hr AP
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and lasts for 18-20hr (He and Adler 2001). Specification of the maxillary palps takes
place entirely after pupariation (Lebreton et al. 2008). In the wing, final patterning of the
veins by decapentaplegic (dpp) takes place during the pupal stage (for review see deCelis
2003). In the leg, induction of bracts by bristle cells takes place between 8 and 28 hrs
after pupariation (del Alamo et al. 2002; Held 2002). Finally, the abdominal cuticle is
patterned almost entirely after pupariation, as the imaginal cells that give rise to the
abdomen (the abdominal histoblasts) do not proliferate and replace the larval epidermal
cells until after this time (Kopp and Duncan 1997; Kopp and Duncan 2002; Lawrence et
al. 2002).

Remodeling of pre-existing larval structures during metamorphosis
Several adult structures are produced by remodeling of larval structures during the pupal
stage. Such remodeling has been studied extensively in neuronal cells and in the heart.
Neuronal remodeling occurs in both the central nervous system (CNS) and in the
peripheral system. In the CNS, the early-born γ neurons (these are born between the
embryonic and mid 3rd larval stages, and project into the γ lobe) of the mushroom bodies
lose their larval axonal projections at 0-18hr AP, and then elaborate new adult-specific
axonal projections during the early pupal stage (24-36hr AP) (Lee et al. 1999). Also in
the CNS, the embryo-born olfactory Projection Neurons (PNs) (these are born in the
embryo, receive input from olfactory receptor neurons in the antennal lobe, and project
into the MB calyx and lateral horn) function in both the larval and adult olfactory system.
These neurons prune their dendrites and axon branches during the first few hours of
metamorphosis and later reinervate the adult mushroom body and lateral horn (Marin et
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al. 2005). The pruning process of both early-born (γ) neurons and embryo-born PNs
requires cell-antonomous reception of ecdysone signaling through the heterodimeric
EcR-B1/Usp ecdysone receptor (Lee et al. 2000; Marin et al. 2005). Another example of
neuronal remodeling in the CNS is the Thoracic ventral (Tv) neurons. The Tv neuron
dendrites are pruned back in the early pupal stage (5-18hr AP), and then establish adultspecific branches in later pupae (18-48hr AP) (Schubiger et al. 1998; Brown et al. 2006).
The pruning of Tv neurons requires the EcR-B1 or EcR-B2 isoforms (Schubiger et al.
1998). The pruning of larval dendrites in Tv neurons seems to result from transcriptional
activation by the EcR complex, but the outgrowth of adult dendrites is more complicated.
The outgrowth could either be a result of EcR-dependent transcriptional activation or a
transcriptional derepression (Schubiger et al. 1998; Brown et al. 2006).

In the peripheral nervous system, some of the dendritic arborization (da) neurons are
remodeled during metamorphosis and function in the adult nervous system. For example,
the larval dendritic arbor of the dorsal da sensory neuron E (ddaE) is pruned back in the
early pupal stage (10-25hr AP), and then regrows to produce the adult arbor at 40-54hr
AP (Williams and Truman 2005). The pruning of dendritic and axonal arbors requires the
EcR-B and EcR-B2 isoforms, but not the EcR-A isoform of the ecdysone receptor
(Schubiger et al. 1998; Lee et al. 2000).

The heart is also remodeled during metamorphosis. The morphology of the heart has been
well characterized: in the embryo and larva, the cardiac tube is derived primarily from
thoracic segment T3 and abdominal segments A1-A7, with segments T3-A4 forming the

7

larval posterior aorta, and segments A5-A7 forming the larval heart. Each segment is
composed of two Seven Up (Svp) expressing anterior myocytes and four Tinman (Tin)
expressing posterior myocytes (Monier et al. 2005). During the remodeling process,
segments T3-A4 differentiate as the adult heart, and segment A5 becomes the terminal
chamber of the adult heart by transdifferentiation. In this process, A5 loses contractile
activity, gains specific innervation, and undergoes changes in cell shape and polarity.
Segments A6-A7 are eliminated by apoptosis (Monier et al. 2005).

Remodeling of the larval heart is accomplished at least in part by the ecdysone-dependent
transcriptional reprogramming of the Hox genes Ultrabithorax (Ubx) and abdominal-A
(abd-A) (Monier et al. 2005). Ubx and abd-A are expressed within the larval aorta and
larval heart, respectively, and are known to specify the identities of these regions (Lo et
al. 2002; Lovato et al. 2002; Ponzielli et al. 2002). During metamorphosis, ecdysone
causes Ubx to change its expression pattern: Ubx becomes repressed in Tin-expressing
myocytes and restricted in expression to Svp-expressing myocytes. Ecdysone has a very
different effect on abd-A: in A5, it causes Abd-A to transition from specifying larval
heart to specifying terminal chamber. This transition involves a shift in the target gene
specificity of Abd-A (see below) (Monier et al. 2005).

Key transcription factors and signaling systems change their target gene specificity in the
transition from larval development to metamorphosis
Several of the metamorphosis-specific patterning events described above are known to
involve dramatic changes in the effects of key transcription factors or developmental
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signaling systems. A good example occurs during wing vein patterning. During larval
life and in the first 8 hr APF, dpp is expressed in wing discs in anterior compartment cells
located along the compartment boundary. At this time, the dpp morphogen shapes the
wing by controlling spalt, optomotor-blind (omb), and other downstream targets (de Celis
et al. 1996; Grimm and Pflugfelder 1996; Nellen et al. 1996). The expression of dpp
along the compartment boundary is activated by Hh, which is secreted by posterior
compartment cells and diffuses across the compartment boundary.

Although hh

continues to be expressed in the posterior compartment of the wing throughout pupal
development, at about 14 hr APF dpp becomes insensitive to Hh signaling, and
expression of dpp along the compartment boundary is lost. At about this same time, dpp
becomes competent to respond to EGFR signaling, which drives dpp expression in the
wing-vein primordia, where it directs the final differentiation of the veins (reviewed in
De Celis 1998; Martin-Blanco et al. 1999; De Celis 2003). Strikingly, expression of
rhomboid, which is required for secretion of the EGFR ligand Spitz, is expressed in
preveins in third instar larval discs as well as in pupal wings. Thus, although both Hh
and EGFR signals are present in both larval and pupal stages, dpp responds only to Hh in
the larva, and only to EGFR signaling in the pupa. The factors that drive this transition in
the competence of dpp have not been identified. The targets of Dpp signaling must
undergo a similar transition during metamorphosis, as Dpp controls genes involved in
patterning the wing blade in the larva, and genes involved in elaborating veins in the pupa.

Many other examples indicate that a distinct regulatory environment exists during
metamorphosis. In the larval heart, Abd-A activates Ih (which encodes a protein for
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intracellular cyclic nucleotide activated cation channel activity) and Ndae1 (Na+-driven
anion exchanger 1), whereas in the pupa during remodeling, Abd-A transitions to
repressing Ih and Ndae1 in the same tissue (Perrin et al. 2004; Monier et al. 2005). In
abdominal development, omb is regulated by Wg in early pupal development, but then
loses its competence to respond to Wg and acquires competence to be activated by Hh
signaling (Kopp and Duncan 1997; Kopp and Duncan 2002; Lawrence et al. 2002).
Maxillary palp development is initiated by expression of Wg in the ventral region of the
antennal disc after pupariation (Lebreton et al. 2008). However, when Wg expression is
driven here in the larva, antennal development is induced (Lebreton et al. 2008). In the
eye, ectopic expression of EGFR signaling has very different effects after pupariation
than before (Freeman 1997).

In the wing, ectopic EGFR signaling induces vein

development early in metamorphosis, but represses it at later times (Martin-Blanco et al.
1999). Additional evidence that a distinct regulatory environment is present during
metamorphosis is provided by the identification of many enhancers that are specific for
the larval or pupal stages. Examples include pupal-specific antennal enhancers from the
spineless (Emmons et al. 2007) and distal antenna related genes (D. Duncan,
unpublished).

A new connection between ecdysone signaling and imaginal patterning during
metamorphosis
It seems very likely that the metamorphosis-specific patterning events described above
and their associated transitions in target gene specificity are controlled by ecdysone
signaling. However, this has been demonstrated to be true only for neuronal remodeling
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and remodeling of the heart. For my thesis work, I have shown that the ecdysone
response gene E93 is required for many imaginal patterning events during metamorphosis,
a finding that establishes a new connection between ecdysone signaling and these events.
Below, I review what is known about E93.

Basic knowledge about E93
E93 was identified as an early puff gene induced by ecdysone (Baehrecke and Thummel
1995). E93 shows tissue-specific regulation not seen for other early ecdysone response
genes. In the larval midgut, E93 is induced by both the larval-prepupal ecdysone pulse at
0 hr APF and by the prepupal-pupal pulse at about 10 hr APF. However, in salivary
glands, E93 is induced only by the second of these pulses (Baehrecke and Thummel
1995). The explanation for this difference is that E93 expression requires bftz-F1, which
is not expressed in the salivary gland until mid-prepupa (Lavorgna et al. 1993; Baehrecke
and Thummel 1995; Broadus et al. 1999). BR-C, E74 and E93 trigger salivary gland
apoptosis by inducing at least two cell death genes, rpr and hid (Lee et al. 2000;
Thummel 2001). Northern blotting of RNA from whole pupae indicates that E93 is
induced until about 48hr AP (Fig. I-3, Fig. V-1, Baehrecke and Thummel 1995).
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Figure I-3: The stage specificity of the expression of E93
E93 is induced by the first and second ecdysone pulses (0hr AP, 10hr AP) in the midgut
and fat body. It is induced by the second ecdysone pulse (10hr AP) in the salivary gland.
Northern blot from the whole animal indicates its expression is sustained until about 48
hr AP. The blue line represents ecdysone pulses; the red line represents the induction of
E93 expression.

In the central nervous system, E93 is activated at 12hr AP, but this activation seems to be
independent of ecdysone in organ culture experiments; in imaginal discs, E93 is induced
mildly at 12hr AP, and input of ecdysone to this induction is unknown; in the fat body
and midgut, E93 responds to both ecdysone pulses at 0hr AP and 10hr AP (Fig. I-4,
Baehrecke and Thummel 1995).

Figure I-4: The tissue specificity of the expression of E93
Northern blot of E93 total RNA from salivary glands, CNS, imaginal disc, fat body and
gut at 0hr and 12hr AP (Baehrecke and Thummel 1995).
The transcriptional products of E93
In their molecular characterization of E93, Baehrecke and Thummel pieced together
several partial cDNAs from the locus to infer a transcript of 9.5 kb that covers some 37kb
of genomic sequence (the red transcript in Fig. I-5, Baehrecke and Thummel 1995).
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Consistent with this transcript size, a transcript of 9.5 kb is detected on Northern blots
using a probe from the 3' UTR (Baehrecke and Thummel 1995). The predicted ORF of
this transcript is 1165 amino acids long (the red shaded region in Fig. I-5). Recently, an
alternate E93 cDNA of 4.5kb was described on FlyBase (LP08695; designated here as
LP0, the green transcript in Fig. I-6). The LP0 cDNA has 3 novel 5' exons and a
shortened 3' exon, and its predicted ORF (the green shaded region in Fig. I-5) encodes a
protein of 1188 amino acids in which the N-terminal 9 amino acids of the E93 ORF are
replaced by an alternate sequence of 32 amino acids. In my own cDNA screening,
another cDNA of 4.6kb (designated Clone 2) was identified (the yellow transcript in Fig.
I-5). Clone 2 has novel 5' exons and a shortened 3' exon, but its predicted ORF (yellow
shaded region) is the same as E93. Since the 5' end of Baehrecke's E93 transcript was
never determined, it is possible that its 5' end is the same as Clone 2.

E93Vnol(3)ry93

Tp(3;3)Vno

E93Vnoe47 E93Vnoe31

E93Vnoe18 E931

LP0
E93
Clone2
17760k

17770K

17780K

17790K

17800K

17810K 17820K 178305K

17840K

Figure I-5: Molecular map of three alternate transcripts of E93
The green transcript represents LP0. The red transcript represents E93. The yellow
transcript represents Clone2. Shaded areas represent the predicted ORF. The black arrows
indicate the breakpoint of the dominant Tp(3;3)Vno mutant and the stop codon positions
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of E93Vnoe31, E93Vnoe47, E93Vnoe18 and E931 mutants respectively. The black triangles are
insertions of two Doc elements and a P-element in the E93Vnol(3)ry93 allele.

The protein homology of E93
E93 is likely a transcription factor, as it contains a pipsqueak (pipsq) domain, which is a
DNA-binding domain (Fig. I-6, pink region, Lehmann et al. 1998; Siegmund and
Lehmann 2002). A second cryptic pipsq domain, which contains amino acid substitutions
within the conserved pipsq domain helix-turn-helix region, is located 385 amino acids
upstream of the canonical pipsq domain (Siegmund and Lehmann 2002). Both domains
have high homology with honey bee Mushroom body large-type Kenyon cell specific
protein-1 (Mblk-1) in two regions, designated as RHF1 (region conserved between
honeybee and fruit fly 1) and RHF2 (Takeuchi et al. 2001). RHF2 is also conserved in the
mammalian proteins Mblk1-related protein-1(Mlr1) and Mlr2 (Kunieda et al. 2003). Mlr1
is expressed in mouse testis, implying a potential role in spermatogenesis (Kunieda et al.
2003). Mblk-1 is expressed in the honeybee mushroom body, where it may be involved in
synaptic plasticity (Takeuchi et al. 2001).
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pipsq

Figure I-6: E93 homologues from other species
Mm (Mus musculus); Hs (Homo sapiens); Am (Apis mellifera); Dm (Drosophila
melanogaster). MM, RHF1 and RHF2 are conserved motifs across species. Red pipsq is
the canonical pipsqueak domain in fruit fly (modified from Kunieda et al. 2003).
The phenotype of E93 alleles
Lee et al. (2000) have described three mutant alleles of E93. These are all defective in
the death of larval midgut and salivary gland cells during metamorphosis (Fig. 1-7 A’).
The E931 allele is associated with a nonsense change at codon 995, near the C terminus
of the coding sequence (Fig. I-5). Sequence changes have not been identified for the
other two alleles (E932 and E933), which are unaffected in their coding sequences. E932
and E933 mutants show reduced accumulation of 9.5 kb E93 transcripts, suggesting that
these alleles affect regulatory sequences of the gene (Lee et al. 2000). Because of the
nature of the E93 product and the phenotypes of these mutant alleles, E93 has been
viewed in the literature as a dedicated regulator of programmed cell death (Lee et al.
2000; Siegmund and Lehmann 2002).

My thesis work grew out of the discovery of three new alleles of E93 that have little
effect on larval cell death, but instead cause numerous defects in pattern formation during
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the pupal stage. These alleles were isolated by Eric Baehrecke in a screen for EMSinduced lethals that fail to complement a deficiency that includes the E93 gene. This was
the same screen that led to the recovery of the E931, E932, and E933 alleles. When
Baehrecke sorted the lethals he recovered into complementation groups, the three new
alleles affecting imaginal patterning were placed into a separate complementation group,
as they fully complement the E931, E932, and E933 alleles. Baehrecke went on to show
that the three mutations fail to complement the dominant wing-vein mutation
Tp(3;3)Vein-off (Tp(3;3)Vno), and so he designated them as Vno alleles (Vnoe18, Vnoe31,
and Vnoe47).

An additional allele [Vnol(3)ry93] was identified in the Bloomington P-

element insertion collection. Because our laboratory was interested in the effects of the
Tp(3;3)Vno mutation on the development of the abdomen, Dr. Baehrecke sent his Vno
alleles to us for analysis. Our lab mapped the P-element insertion in Vnol(3)ry93 to be
1.5kb upstream of the 5' end of the E93 transcripts (see Fig. I-5) and then identified the
Vnoe47, Vnoe31 and Vnoe18 mutants as nonsense mutations in codons 360, 545, and 783,
respectively of the 1165 codon E93 sequence (Fig. I-5). We also showed that Tp(3;3)Vno
has a breakpoint located 36-37kb upstream of E93 (Fig. 1-5). In light of these findings,
the Vno mutations were renamed E93Vnoe18, E93Vnoe31, E93Vnoe47, and E93Vnol(3)ry93.

E93Vno alleles fully complement the E931, E932, and E933 alleles, and hemizygotes show
almost normal midgut and salivary gland cell death after pupariation. However, E93Vno
mutants do show numerous defects in imaginal patterning. Wing veins are completely
absent, the abdominal tergites are only partially formed, most chemosensory sensilla are
absent in the antenna and palp, the arista fails to branch, 2˚ and 3˚ pigment cells fail to be
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specified properly in the eye, and bracts fail to form in the leg (Fig I-7). Strikingly, all of
these defects are in structures that are patterned during metamorphosis. Our lab has
failed to find any defects in E93Vno mutants prior to pupariation; even hemizygous mutant
larvae from homozygous mutant germ line mothers develop normally until this time.
This stage-specificity suggests that E93 encodes a metamorphosis-specific cofactor
required in many imaginal patterning processes. My working hypothesis is that E93
directs many of the pupal-specific target gene transitions described above. My studies
help establish a connection between ecdysone signaling and imaginal patterning during
metamorphosis and are likely to provide important new insights into the temporal control
of target gene specificity for key signaling systems used in development. Why the E93Vno
alleles complement the E931, E932, and E933 alleles has been difficult to understand, and
is addressed in Chapter IV of my thesis.
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Figure I-7: The phenotype of E931 alleles and E93Vno alleles
A: Wild-type (E931/+) pupa at 24hr AP; salivary glands have been eliminated by this
time (asterisk); but other tissues formed normally: adult eyes (e), brain (b), and adult
wings (w). A’: E931/Df pupa at 24hr AP; redline circle the persistent salivary glands (sg)
(Lee et al. 2000). B-F are wild type; B’-F’ are E93Vno mutants. B and B’ are legs (bracts
are marked by arrows). C and C’ are wings. D and D’ are abdomen. E and E’ are antenna.
F and F’ are eyes. The red lines outline the shape of cone cells in ommatidia.

Summary of my work
Through my four and half years work in Dr. Ian Duncan’s lab, I have made progress in
the following areas (detailed information presented in Chapter II-V separately).
1) Determination of the protein expression profile of E93.
2) Determination of the position of E93 in the signaling pathway leading to the
formation of bracts.
3) Dissection of E93 protein domains required for its cell death and patterning
functions.
4) Identification of E93 transcripts responsible for the cell death and patterning
functions of E93.
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Chapter II : Determination of the protein expression profile of E93

Abstract
I designed antigens from three regions of the E93 coding sequence, produced these
proteins in E. coli, and used them to immunize rabbits and mice either as single or mixed
E93 antigens. The E93 antisera obtained allowed the immunostaining of E93 in pupal
tissues. E93 is detected in the antenna, arista, eye, labellum, wing and leg in the pupal
period, consistent with the multiple imaginal defects seen in E93Vno mutants.

The

E93Vnoe47 mutant shows dramatically reduced staining, demonstrating specificity of the
antisera.

Rationale
Although expression of E93 has been characterized early in metamorphosis in the larval
midgut and salivary gland (Lee et al. 2000), later expression in imaginal tissues has not
been examined. An E93 antiserum (against codon 279-837) was generated by Dr. Eric
Baehrecke (Lee et al. 2000). However, this antiserum did not work well for Western
blotting or tissue staining (personal communication), and is no longer available. In order
to gain a more complete picture of the expression of E93 during metamorphosis, it
became necessary to generate a new E93 antiserum.

Methods
DNASTAR Lasergene 7 software was used to predict three regions with high antigenicity
(Antigen I, II, and III, which include codons 47-126, 285-400, 999-1125 respectively (Fig.
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IV-1); detailed sequence information can be found in the Appendix). These three regions
were amplified and cloned into the pET28a vector by EcoRI and HindIII double digestion.
Expression was induced in BL21 (DE3) cells, and proteins purified by His-Bind nickel
chromatography, followed by dialysis in PBS overnight.

Preimmune serum was

collected from animals prior to immunization, and stored in 50% glycerol at -70˚C.
Mixtures of the 3 antigens were injected into 2 rabbits (Rabbit A and Rabbit B) and 3
mice (Mice 1-3). Individual antigens (antigens I-III) were injected into 3 mice separately
(Mice 4-6). Rabbits were immunized 6 times with 110ug of protein at 1 month intervals.
Mice were immunized 6 times with 10ug of protein at 1 month intervals. All
immunization and bleeding procedures followed standard protocols. Sera were stored in
50% glycerol at -70˚C. Rabbit B generated strong immune response in the 1st bleeding,
and then the strength of the immune response went down (tested bleedings include
preimmune, 1st, 2nd, 3rd and 6th bleeding). Rabbit A didn’t generate good immune
response in the 1st bleeding, and the strength of the immune response didn’t get better
until the 6th bleeding (tested bleedings include preimmune, 1st, 2nd, 3rd, and 6th). And even
the strongest response from Rabbit A (6th bleeding Rabbit A) is weaker that the weakest
bleeding from Rabbit B (1st bleeding from Rabbit B). All mice sera, except Mouse 4,
generated good immune response, and the strength of the immune response got better and
better in each bleeding (tested bleedings include Mouse 1 preimmune, 1st, 2nd, Mouse 2
preimmune, 2nd, Mice 3-6 preimmune, 1st, 2nd, 3rd). More details of the bleeding tests are
available in the Appendix. The specificity and authenticity of tests of E93 antisera are
shown in the Result section.
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Antibody staining was by standard methods. Embryos were dechorionated in 50% freshly
diluted Chlorox for 3 minutes, and fixed in 8ml PMG buffer (0.1M PIPES, 2 mM EGTA,
1 mM MgSO4, pH 6.9), 10ml heptane, and 2ml 37% formaldehyde for 20 minutes, and
devitellinized in 100% MeOH. Larvae and pupae were staged and fixed in 4%
paraformaldehyde. For 1̊ antibodies, chicken anti β -gal was used at a dilution of 1:200
and all others (rabbit anti E93, mouse anti E93, mouse anti Distal-less (Dll), rabbit anti
Pointed.P1) were used at 1:400. 2˚ antibodies (anti chick, anti rabbit, or anti mouse) were
all used at 1:200.

Images were taken using a Leica TCS SP 2 confocal system, or a Zeiss Photomicroscope
III.

Results
The specificity and authenticity of E93 antisera
Previous experiments indicated that E93 protein is expressed in midgut cells beginning at
around 2hr AP and disappearing by about 13hr AP, whereas in the salivary gland, E93
protein is not detected until around 10 hrs AP (Lee et al. 2000). With one exception, all
rabbit and mouse antisera against E93 gave the expected result for staining of the midgut:
positive nuclear staining was seen at 2hr AP (Fig. II-1 A), whereas staining was lost by
13hr AP (data not shown). The antiserum from mouse 4, which was immunized with
antigen I alone, did not show positive staining in midgut. Staining of salivary glands was
not as expected: antiserum from mouse 1 showed weak staining of salivary nuclei in both
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13hr (Fig. IV-5 E) and 2hr AP pupae, but not in larvae. Mouse 2 showed weak staining of
salivary nuclei in 2hr AP pupae, but not in larvae. Mice 3, 5 and 6 showed weak staining
of salivary nuclei in both 2hr AP pupae and larvae. Rabbits A and B showed weak
staining of salivary nuclei in larvae, but not in 2hr pupae. The reason for these
complicated staining results for salivary glands has not been explored further.

Two lines of evidence demonstrate the specificity of the mouse and rabbit antisera
generated. First, E93Vnoe47 hemizygotes show a dramatic reduction in staining in both
imaginal (bract - see below) and midgut cells (Fig. II-1 C, D). Second, both mouse and
rabbit antisera detect full length E93 protein expressed in en-Gal4; UAS-E93 embryos
(Fig. II-1 B). The rabbit antisera also show some staining in the anterior gut of the
embryo. This staining is likely due to cross reaction, as it is not reduced in the E93Vnoe47
mutant, and is not seen with the mouse antisera. Antisera from mice injected with single
antigens show the expected staining specificity when used to stain embryos in which enGal4 is used to drive expression of fragments of E93 (UAS-E931Nterm and UASE93Vnoe47Cterm, see their molecular map in Fig. IV-1) (Fig. II-1 E-L). Rabbit antisera
were used for most of my experiments, as they are abundant. Mouse antibodies were
used only when required for double or triple antibody staining.
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Figure II-1: E93 antigen authenticity tests
A: Wild-type 2hr midgut stained by E93 antiserum from Mouse 3; B: Embryo carrying
en-Gal4>UAS-ORF-D1 stained by E93 antiserum from Rabbit B; C: Wild-type pupal leg
at about 35hr AP stained by E93 antiserum from Rabbit B; D: E93Vno mutant pupal leg
stained by E93 antiserum from Rabbit B; E-H are embryos carrying en-Gal4>UASE931Nterm and UAS-GFP; I-L are embryos carrying en-Gal4>UAS-E93Vnoe47Cterm and
UAS-GFP; E, G, I and K are GFP positive controls to show that en-Gal4 drives UAS
constructs in the expected pattern; F and J are stained by E93 antiserum II (Mouse 5); H
and L are stained by E93 antiserum III (Mouse 6); F and L suggest antisera from Mouse 5
and Mouse 6 are specific to antigens II and III, respectively

The expression profile of E93 in WT
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When I stained wild-type pupae between 20-60hr AP, I detected E93 in multiple tissues.
In general, E93 is expressed strongly between 30-35hrAP, and then gradually declines.
At 30-35hr AP, E93 is expressed in every cell of antennal segments II and III (Fig. II-2
A), throughout the wing (Fig. II-2 B, E), and in future pseudotracheal cells
(pseudotracheae are hollow tubes on the surface of the labellum used for feeding) in the
labellum (Fig. II-2 D).

In the eye, E93 is expressed in a complex pattern in each

ommatidium (Fig. II-2 C, F), and in the leg, E93 is expressed in single cells located just
proximally to each bristle (Fig. II-2 G, H). In chapter III, these cells are identified as
producing the leg bracts.

The expression of E93 detected by immunostaining

corresponds well to the structures that are affected in the E93Vno mutants. As described
above, E93 is also expressed in the nuclei of midgut caeca at 2hr AP (Fig. II-1 A), but
disappears quickly and is not detected at 13hr AP (data not shown). E93 expression in the
salivary gland is weak and variably detected by the different antisera.
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Figure II-2: The expression profile of E93 in multiple tissues during metamorphosis
Wild-type tissues at 30-35hr AP stained by E93 antiserum from Rabbit B. A: Antenna
and arista; B: Wing; C: Ommatidia (top scanning); D: Labellum; E: Wing (enlarged
scanning of B); F: Ommatidia (bottom scanning); G: Leg (top scanning); H: Leg (bottom
scanning).

E93 expression in E93 mutant hemizygotes
Both the E93Vno alleles (including E93Vnoe47, E93Vnoe31, and E93Vnoe18) and the alleles
affecting larval cell death (E931, E932, and E933) cause a strong reduction in E93 staining
in 1-5hr AP midgut cells in hemizygotes (see Figure IV-3). Hemizygotes for the E93Vno
alleles also show strongly reduced E93 staining in prebract cells in 30-50 hr AP legs (Fig
IV-3). Hemizygotes for E931, E932, or E933 die early in pupal development, precluding
examination of expression in bract cells in these mutants.

Discussion
The detection of E93 in the antenna, arista, ommatidia, wing and leg is consistent with
the observation that E93Vno mutants cause patterning defects in these tissues. The finding
of E93 expression in the pseudotracheal cells of the labellum was a surprise, and suggests
the involvement of E93 in the development of these structures although we haven’t
checked whether E93Vno mutants affect their development. Based on our hypothesis that
E93 functions as a metamorphosis-specific cofactor, our expectation was that E93 would
prove to be expressed very broadly in imaginal tissues in the pupal stage.

This

expectation was borne out in the wing and antenna, where E93 is expressed in all or
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almost all cells. However, in the eye and leg, E93 shows highly restricted expression
patterns. The identities of E93-expressing cells in the eye have not been determined, but
in the leg, expressing cells have been identified as future bract cells (see Chapter III). As
described above, bracts fail to develop in the E93Vno mutants. The picture that emerges
for E93 is similar to that seen for the Hox genes. Initial descriptions of the expression
patterns for Hox genes were a great surprise, as genetic studies had suggested these genes
would prove to be expressed uniformly within each developmental compartment. Such
uniformity was often found, but in some cases expression was limited to only specific
structures within compartments. One example from the recent literature is the finding
that the Hox gene Scr, which controls first thoracic segment identity, is strongly
upregulated in the sex comb region of the male first leg (Randsholt and Santamaria 2008).
A likely possibility is that in the ancestral state Scr was expressed uniformly in the male
T1 leg, where it came to specify sex comb development in the male among other T1specific structures. Selection for increased development of the sex comb then led to
selection for increased expression of its positive regulators, including Scr. In response,
Scr became incorporated into the patterning system that positions the sex comb, leading
to high level expression within this specific structure. If our working hypothesis (that
E93 functions as a metamorphosis-specific cofactor) is correct, a similar series of events
could have occurred in the evolution of high level E93 expression in bract cells.

The E931, E932, and E933 mutants all cause strong reductions in E93 staining in the 2 hr
AP midgut, consistent with the failure in larval cell death seen in these mutants. The
E93Vno mutants also cause a strong reduction of E93 staining in midgut cells, as well as in
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the pre-bract cells of the pupal leg. Why, then, do the E93Vno alleles almost fully
complement the E931, E932, and E933 alleles? One possibility is that the cell death
function of E93 is executed by an alternate product of the locus, a possibility that is
explored further in Chapter V. The problem of the complementation of the E93Vno alleles
and the alleles affecting larval cell death is addressed more fully in Chapter IV.

28

Chapter III : Determination of the position of E93 in the signaling pathway leading
to the formation of bracts

Abstract
In order to understand the role of E93 in imaginal patterning, I focused on a single E93dependent process, the induction of bracts in the legs. Bracts are small pigmented
outgrowths that lie just proximal to most bristles in the legs. They are patterned in the
mid pupal stage by a relatively simple process: bristle or bristle-associated cells secrete
the EGFR ligand Spitz, which induces bract formation in an adjacent epidermal cell (del
Alamo et al. 2002; Held 2002). In mosaic studies, I demonstrated that E93 is required in
the epidermal (signal receiving) cell for bract formation. I showed that argos, a common
target of EGFR signaling, is induced in the pre-bract cell in normal development. This
induction is unaffected in E93Vno mutants, indicating that E93 lies downstream of the
EGFR signaling pathway in bract development. We were surprised to find that E93 is
expressed in a very restricted pattern in the pupal leg: expression is restricted to single
cells lying just proximal to each bristle. Double labeling experiments show that these
E93-expressing cells coincide with Distal-less (Dll) expressing cells, which are fated to
produce bracts. I show that expression of Dll in these cells requires E93+, and that
expression of E93 in turn requires Pointed (Pnt), a transcription factor that lies at the end
of the EGFR signal transduction pathway. Ectopic expression experiments show that
E93 is permissive for bract formation, whereas Pnt is instructive. These findings suggest
that E93 and Pnt work in concert to specify bract development, with E93 providing
temporal information and Pnt providing spatial information. Still unresolved is the role
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of ecdysone signaling in the bract pathway: clones expressing an RNAi construct directed
against a common region of the ecdysone receptor show some loss of bracts, indicating a
requirement for ecdysone signaling. However, it is not yet clear whether ecdysone is
required for E93 expression in bract cells.

Rationale
The major goal of my dissertation is to determine the role of E93 in patterning during
metamorphosis. Why should E93 be required for patterning in the pupa, but not at other
times? Our hypothesis is that E93 is a metamorphosis-specific cofactor that confers
pupal specificity to the targets controlled by a number of transcription factors. Such a
role would help account for numerous cases in which signaling pathways or transcription
factors exert metamorphosis-specific effects (see Introduction).

To understand the role of E93, we focused on a single E93-dependent process. We
decided to focus on bract formation in the leg because of its simplicity and the
availability of a potential downstream target gene Dll. Bracts are pigmented outgrowths
of unknown function that are located just proximal to each mechanosensory bristle (Fig.
I-3 B arrows). They are completely absent in the E93Vno mutants (Fig. I-3 B’). Previous
studies have shown that bristle cells, or cells associated with bristle cells, secrete the
EGFR ligand Spitz, which induces a neighboring epidermal cell to become a bract
through the EGFR signaling pathway (del Alamo et al. 2002). One potential target of
EGFR signaling in these cells is the homeobox gene Dll, which is expressed in pre-bract
cells beginning in mid pupal development, and is required for bract formation (Campbell
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and Tomlinson 1998; Emmons et al. 2007). Since the EGFR signaling pathway activates
numerous downstream targets in different contexts, we hypothesized that E93 might
serve as a metamorphosis-specific cofactor that controls the specificity of EGFR
signaling in the pupal leg, targeting the Dll gene for activation (Fig. III-1).

Bract cell

Bristle cell

Enlarged bract cell

E93?
EGFR

Ras

Pointed

Distal-less
Argos

Figure III-1: Genes in the EGFR signaling pathway that may play potential roles in
bract formation.
The green arrow represents the EGFR ligand sent out from the bristle cell. Dotted lines
indicate that other genes are omitted from the pathway.

Methods
E93Vno clones were generated by crossing y w FLP122; FRT82B CD2 y+ M(3)W Bsb /
TM6B ♀ to FRT82B sr es E93Vnoe47 ca/TM6B ♂, and then heat shocking larvae at 37˚C
for 30 minutes. Adult legs were mounted in a mixture of 38% Shandon Immu-Mount,
53% filtered saturated chloral hydrate, and 10% filtered lactic acid, and placed on a slide
warmer for 2 days at 45˚C. E93Vno clones were identified by scoring the yellow marker in
the cuticle of non-Tubby ♂ flies using a Zeiss Photomicroscope III.
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For cuticular analysis, pnt- clones were generated by crossing y w FLP122; FRT82B CD2
y+ M(3)W Bsb / TM6B ♀ to FRT82 roe pp cu sr pntΔ88/TM6B ♂. Heat shock and
preparation of legs was as described above. pntΔ88 is a null deletion allele of pnt (Scholz
et al. 1993). For analysis by confocal microscopy, pnt- clones were generated by crossing
y w FLP122; FRT82 Ubi-GFP83/TM6B ♀ with FRT82 roe pp cu sr pntΔ88/TM6B ♂,
followed by heat shocking larvae at 37̊C for 30 minutes.

pnt- clones were identified as

GFP minus clones in non-Tubby pupae.

EcR-RNAi knock down clones were generated by crossing y w FLP12; Act>y+>Gal4
UAS-GFP ♀ with UAS-EcR-RNAi ♂. EcR-RNAi knock down clones were identified by
confocal microscopy as GFP positive clones in pupae, or as yellow clones in the cuticle of
♂ flies using a Zeiss Photomicroscope III.

E93 ectopic expression clones were generated in E93Vnoe47 mutant animals by crossing y
w FLP12; Act>y+>Gal4 UAS-GFP; tub-Gal80ts E93Df/TM6B ♀ with UAS-E93-ORF;
E93Vnoe47/TM6B ♂. Progeny were raised at 25˚C until young larvae, and were heat
shocked at 37˚C for 7 min. Larvae were then moved to 19˚C until the early pupal stage,
when they were shifted to 30̊C. Legs from non -Tubby pharate pupae were mounted as
described above. E93 ectopic expression clones were identified by scoring the yellow
marker in the cuticle of non-Tubby ♂ flies using a Zeiss Photomicroscope III.

Antibody staining and imaging were as described in Chapter II.
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Results
E93 is required in the bract cell for the bract formation
To determine whether E93 is required in the bristle (signal sending) cell or the bract
(signal receiving) cell in the bract pathway, I generated mosaics for the E93Vnoe47 allele.
In these mosaics, cells homozygous for E93Vnoe47 are marked by yellow cuticle. The four
possible genotypic combinations for bristle and bract cells are shown in Fig. III-2 A. If
E93 is required in the bristle cell, then only wild-type bristles (black bristles) can send out
the right signal to the neighboring cells and induce bracts, but the bracts themselves could
be either mutant (yellow) or wild type (black) (Fig. III-2 C). Conversely, if E93 is
required in bract cells, then only wild-type bracts (black bracts) will be induced, but
bristles could be either mutant (yellow) or wild type (black) (Fig. III-2 D). The second
result was obtained, indicating that E93 is required in the bract cell but not the bristle cell
(Fig. III-2 B).
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Figure III-2: Mosaic clones show E93 is required in the bract cell
A: Four possible genotype combinations of bristle and bract cells. I: black bract, black
bristle. II: yellow bract, black bristle. III: black bract, yellow bristle. IV: yellow bract,
yellow bristle. B: When E93Vnoe47 clones are marked by yellow, only wild-type black
bracts are seen. C: If E93 is required in the bristle, then only black bristles will be able to
induce bracts (either I or II). D: If E93 is required in the bract, then only black bracts will
be present (either I or III).

E93 is epistatic to Ras in bract formation
Since E93 is not required in the bristle, we shifted our attention to determining where E93
acts in the EGFR signaling pathway in bract cells. An important component of this
pathway is Ras (Gilbert 2003). Previous studies have shown that ectopic expression of
activated Ras between 8-12 hr AP transforms most epidermal cells of the distal leg into
bracts (del Alamo et al. 2002; Held 2002). When I drove expression of hs-RasV12 (a
constitutively active form of Ras) between 18-22hr AP, extra bracts were induced (Fig.
III-3 A). However, when I heat shocked hs-RasV12 between 18-22 hr AP in an E93Vno
mutant background, no bracts were induced (Fig. III-3 B), indicating that E93 lies
downstream of Ras in the bract pathway.
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Figure III-3: Epistasis relationship of E93 and Ras
A: Heat shock of hs-RasV12 between 18-22 hr AP induces extra outgrowths of epidermal
cells that look like bracts. B: Heat shock of hs-RasV12 between 18-22 hr AP in the
E93Vnoe47 mutant background does not induce bracts, indicating that E93 is epistatic to
Ras.

E93 functions downstream of the EGFR signal transduction pathway
A target of EGFR signaling in almost all contexts is the gene argos, which encodes a
secreted antagonist of the Spitz EGFR ligand (Freeman et al. 1992; Schweitzer et al.
1995). To determine whether argos is also activated during bract induction, I examined
expression of argos-lacZ in pupal legs. LacZ expression was found to occur immediately
proximal to each bristle in the pupal leg (Fig. III-4 A). This observation suggests that the
secretion of the Spitz ligand is polarized toward the proximal side of each bristle,
accounting for why bracts develop only to the proximal side of bristles. I then examined
argos-lacZ expression in the E93Vnoe47 mutant background: lacZ expression was
unaffected relative to E93+ animals (Fig. III-4 D). This finding demonstrates that the
EGFR signal transduction pathway is intact in E93Vno mutants, and suggests that E93 acts
downstream of this pathway. When I stained argos-lacZ pupal legs for both lacZ and
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E93 expression, I found that the two co-localized to the same cells, which turn out to be
pre-bract cells (Fig. III-4 C).

Figure III-4: Relationship of E93 and Arogs
A: argos-lacZ expression is detected proximal to each bristle in an argos-lacZ
E93Df/TM6B pupal leg (35-45 hr AP). B: E93 is also detected proximal to each bristle. C:
A merged picture shows that lacZ and E93 co-localize to the same cells. D: argos-lacZ
expression is intact in the E93 mutant background (argos-lacZ E93Df/E93Vnoe47). E: E93
expression is strongly reduced in the E93 mutant background. F: Merged image.

E93 acts upstream of Dll in bract formation
Dll is known to be expressed in bract-associated cells in newly emerged adults, and to be
required for bract formation (Gorfinkiel et al. 1997; Campbell and Tomlinson 1998). In
Dll-Gal4; UAS-GFP newly emerged adults, GFP is expressed in bract-associated cells
(Fig III-5 A). However, in the E93Vnoe47/Df mutant background, GFP expression is not
seen in these cells (Fig III-5 B), indicating that E93 lies upstream of Dll in the bract
pathway. I then stained pupal legs for endogenous Dll protein, and found expression in
cells located just proximal to each bristle (Figure III-5 D). Double and triple labeling
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experiments demonstrated that Dll is expressed in the same cells as E93 and argos-lacZ
Fig. III-5 D and Fig. III-6 C). When I stained for Dll expression in the E93Vnoe47 mutant, I
found that bract expression of Dll was eliminated (Fig. III-5 G and Fig. III-6 F),
indicating the E93 functions upstream of Dll in the bract pathway.

Figure III-5: Epistasis relationship of E93 and Dll
A: Dll-Gal4>UAS-GFP in a wild-type pupal leg; B: Dll-Gal4>UAS-GFP in a
E93Vnoe47/Df pupal leg; C-E: A wild-type pupal leg stained for E93 and Dll; F-H: An
E93Vno mutant leg (E93Vno/Df) stained for E93 and Dll; C, F: E93 expression; D, G: Dll
expression; E, H: Merged images.
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To confirm these experiments, I performed triple labeling with all three antibodies. In
wild-type legs, all three proteins co-localize to the same cells. In the E93Vnoe47 mutant,
E93 and Dll are reduced, but argos-lacZ staining is unaffected.

Figure III-6: Relationship of Argos, E93, and Dll
A-C: A wild-type pupal leg stained for argos-lacZ, E93, and Dll expression; D-F: An
E93Vnoe47 mutant (E93Vnoe47/Df) pupal leg stained for argos-lacZ, E93, and Dll.; A, D:
argos-lacZ expression; B, E: E93 expression; C, F: Dll expression.

The temporal and spatial relationship of E93 and Pnt
In most cases, EGFR signaling is executed by the transcription factor Pointed (Pnt). To
determine whether Pnt is required for bract formation, we generated pnt- clones that were
marked by yellow. Such clones lack bracts. Although black bracts can form adjacent to
yellow or black bristles, yellow bracts are never seen, indicating that pnt+ is required
within bract cells and not bristle cells (Fig. III-7 A). I then examined pnt- clones (marked
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by loss of GFP) in pupal legs by confocal microscopy. In large pnt- clones both E93 and
Dll expression are lost (Fig. III-7 D-G), indicating that both E93 and Dll lie downstream
of pnt in the bract pathway. In small pnt- clones, E93 and Dll expression are seen
occasionally (Fig. III-7 H-K). Presumably this expression is due to perdurance of Pnt in
these clones. Although the expression of E93 and Dll are not affected in small clones, the
positional pattern of transverse rows can be altered (compare the transverse row pattern
in Fig. III-7 K with Fig. III-9 I). Since E93 is required for Dll expression (see above),
these results position E93 between Pnt and Dll in the bract pathway.
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Figure III-7: Pnt is required for the bract formation and functions upstream of E93
and Dll
A: pnt- clones in the leg lack bracts (classes I-IV are as explained in Fig. III-2 A); B:
Over expression of Pnt.P1 between 12-24 hr AP induces extra bracts (red arrows); C:
Over expression of Pnt.P1 between 24-60 hr AP eliminates bracts; D, H: pnt- clones are
identified by the lack of GFP; E, I: E93 expression; F, J: Dll expression; G, K: merged
images. The white outlines in D, E, F and G show the twin spots: the GFP positive spot is
homozygous for pnt+, the GFP minus spot is homozygous for pnt-.

When I over expressed UAS-pnt.P1 by heat shock, the effect on bract formation
depended upon timing. Heat shocks delivered between 12-24 hr AP caused ectopic
bracts to form at the base of many bristles (red arrows Fig. III-7 B). However, when heat
shocks were administered at 24-60 hr AP, bract formation was suppressed (Fig. III-7 C).

To explore the relationship between Pnt and E93 further, I obtained an antiserum raised
against Pnt.P1 by Dr. James Skeath. Double labeling with this antibody and anti-E93
reveals that at 30 hr AP both E93 and Pnt co-localize to bract cells (white arrows in Fig.
III-8 C). However, in later pupae (35 hr AP), Pnt expression is reduced in bract cells (i.e.
E93-expressing cells) but becomes elevated in two cells flanking the bract cell (white
arrows in Fig. III-8 F and Fig. III-9 I). This temporal change in expression correlates
with the stage specific effects of Pnt.P1 ectopic expression. In the early pupa, Pnt is
expressed in the future bract cell, where it activates E93 expression. Ectopic expression
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of Pnt.P1 at this time induces ectopic bract formation (Fig. III-7 B). Later, when Pnt is
down regulated in bract cells, bracts are repressed by ectopic Pnt.P1, perhaps because Pnt
now represses E93 (Fig. III-7 C).

Figure III-8: The temporal specific positional relationship of Pnt and E93
A-C: The distal tibia of a wild-type first thoracic leg at 30 hr AP; D-F: The distal tibia of
wild-type first thoracic leg at 35 hr AP; A, D: Pnt expression; B, E: E93 expression; C, F:
merged images.

Not all bristles develop bracts in the leg. For example, the prominent transverse rows of
bristles present in the distal part of the tibia of the first leg do not develop bracts, whereas
transverse rows of bristles in the basitarsus do (Fig. III-9 B, Tokunaga and Stern 1965
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Tokunaga 1962). By 35 hr AP, E93 expression is mostly lost from these transverse rows
in the distal tibia, whereas Pnt expression is maintained (white arrow heads in Fig. III-8 F
and Fig. III-9 F). In contrast, E93 expression is sustained in cells of the future transverse
rows in the basitarsus, whereas Pnt expression is reduced in these cells and elevated in
adjacent cells (white arrows in Fig. III-9 I). The continued expression of Pnt in cells that
lose E93 expression, and the repression of Pnt in cells that maintain E93 expression,
suggest that E93 or Dll may repress pnt at 35 hr AP.
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Figure III-9: The positional relationship of E93 and Pnt
A: Junction area of the tibia and basitarsus of the first leg of the fly. Transverse rows in
the distal tibia have no bracts, but the transverse rows in the basitarsus do. B: Schematic
summary of bristles and bracts in the distal tibia and basitarsus of the first leg (Tokunaga
1962; Tokunaga and Stern 1965 ). Circles represent bristles, triangles represent bracts, 18 represent longitudinal bristle rows, transverse rows (t), preapical bristle (PA), apical
bristle (A), central bristle (C), sex comb (SC). C: A merged picture of pupal leg (34-36hr
AP) with Pnt and E93 expression. D-F: The enlarged distal tibia area in C. G-I: The
enlarged basitarsus area in C.

The relationship of E93 and bristle precursor cells
To determine the relationship between E93 expression and cells of the bristle lineage, I
examined the neuralized enhancer trap A101, which is expressed in sensory organ
precursor cells and their descendants (Huang et al. 1995). By 35 hr AP, sensory organ
precursor cells have divided so that A101 is expressed in clusters of 3 or 4 cells (Fig. III10 A). Double labeling reveals that E93 is expressed strongly in one of these cells, and
weakly in an A101 positive cell lying just distal (cell B and cell A in Fig. III-10 N). This
observation is surprising, as clonal analysis experiments show clearly that bracts are not
related by lineage to bristle cells (e.g. Fig. III-2 A). Therefore, one would not expect E93
to be expressed in cells of the sensory organ precursor lineage. One possibility is that
A101 expression in the strongly positive E93 cells is induced by neighboring A101
positive cells. The possibility of such induction has been raised previously (Huang et al.
1995). Pnt is expressed weakly in the E93 positive cell (cell 2 in Fig. III-10 O), but
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strongly in two flanking cells (cell 4, 5 in Fig. III-10 O). In the first leg transverse row
bristle rows that have no bracts, E93 expression is dramatically reduced (cell A, B in Fig.
III-10 N), whereas Pnt expression remains high (cell B in Fig. III-10 O).
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Figure III-10: The positional relationship of E93, Pnt, and A101 expression in 35hr
AP legs
A-D: A wild-type leg at 35 hr AP; E-H: enlarged view of the white box on the left in D;
I-L: Enlarged view of the white box on the right in D; M-P: Schematic summary of
protein expression profile of bristles with or without bracts; cells 1-5 will give rise to
bristles with bracts; cells A-E will give rise to bristles without bracts; A, E, I, M: A101
expression; B, F, J, N: E93 expression; C, G, K, O: Pnt expression; D, H, L, P: Merged
images.

Double labeling experiments reveal that Dll has the same temporal and spatial expression
pattern as E93: Dll co-localizes with E93 in the future bract cell (arrow heads in Fig. III11 D, H), and at 35 hr AP is flanked by cells expressing Pnt (Fig. III-11 L). In addition,
Dll is repressed in transverse rows that do not develop bracts (arrows in Fig. III-11 D),
but expressed in transverse rows that do develop bracts (arrows in Fig. III-11 H).
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Figure III-11: The positional relationship of Pnt, E93, Dll, and A101 expression
A-L: Wild-type legs at 35hr AP; A-D: Distal tibia of the first leg; E-H: Basitarsus of the
first leg; I-L: Regular bristles with bracts; A, E, I: A101 expression; B, F: E93 expression;
J: Pnt expression; C, G, K: Dll expression; D, H, L: Merged images.

Ecdysone signaling is required for bract formation
The finding that E93 is expressed specifically in bract cells and lies between pnt and Dll
in the bract pathway raises the possibility that the role of E93 in bract formation is quite
distinct from its role as an ecdysone response gene. To determine whether ecdysone
signaling is required for bract formation, I reduced ecdysone receptor activity by RNAi
(targeting a common fragment of all EcR isoforms, Colombani et al. 2005) in mosaic
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clones (in y w FLP; Act>y+>Gal4 UAS-GFP/UAS-EcR-RNAi). Bracts are reduced in
size or absent in the ecdysone receptor RNAi clones (marked by yellow), indicating that
ecdysone signaling is involved in bract formation (Fig. III-12 A). To determine whether
loss of ecdysone receptor activity also causes loss of E93 and Dll expression in bract cells,
I examined the E93 and Dll expression in EcR knock down clones (marked by GFP
positive cells). Preliminary data show that E93 and Dll are still expressed robustly in EcR
knock down clones. Additional work will be required to determine whether these clones
have no effect on E93 expression because EcR is not required for E93 bract expression,
or because of perdurance or incomplete knock down of EcR.

Figure III-12: Ecdysone signaling is involved in bract formation
A: Most bracts are eliminated in the ecdysone receptor knock down clones (marked by
yellow); B: EcR knock down clones are marked by GFP positive cells; C: E93 expression;
D: Dll expression; E: Merged images.

Is expression of E93 instructive or permissive in bract formation?
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At the outset of my work on bracts, my hypothesis was that E93 provides a temporal
signal that facilitates activation of Dll in bract cells by other spatially restricted
transcription factors (presumably Pnt).

The finding that E93 itself is restricted in

expression to bract cells very much clouded the situation.

Is spatially restricted

expression of E93 important for bract specification? To answer this question, I generated
clones that ectopically express E93 in an E93Vnoe47 mutant background leg. The GAL80ts
method (McGuire et al. 2004) was used to restrict ectopic expression in these clones to
the pupal stage. When such clones are generated in an E93Vnoe47 mutant background, bract
development is often fully rescued proximal to bristles, but ectopic bracts are never seen
(Fig. III-13). This result demonstrates that spatially restricted expression of E93 is not
required for bract formation, and that E93 plays a permissive, not instructive, role in bract
formation. Such a permissive role is consistent with our hypothesis that E93 provides
primarily temporal rather than spatial information during bract formation.
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Figure III-13: E93 expression is permissive in bract formation
E93 is ectopically expressed in E93Vnoe47 mutant background by UAS-E93-ORF clones
(marked by yellow in y w FLP12; Act>y+>Gal4 UAS-GFP/UAS-E93-ORF; tub-Gal80ts
E93Df/ E93Vnoe47 animals). Bracts are formed proximal to bristles, but not elsewhere in
the clone.

Discussion
My experiments establish that E93 lies downstream of pnt and upstream of Dll in the
bract induction pathway. The key lines of evidence that support these conclusions are: 1)
mosaic studies demonstrate that E93 is required within the bract cell, 2) argos-lacZ is
activated normally in bract cells in E93Vno mutants, indicating that E93 acts downstream
of the EGFR signal transduction pathway, 3) pnt- clones lose bract expression of E93,
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indicating that E93 lies downstream of pnt, and 4) E93Vno clones lose expression of Dll in
bract cells, indicating the E93 lies upstream of Dll in the bract pathway.

Is the bract pathway a simple linear pathway in which pnt activates E93, which then
activates Dll? The results of my E93 ectopic expression experiment would argue not. In
this experiment, I demonstrated that leg clones expressing E93 in an otherwise E93Vno
mutant background rescue bracts in their normal location proximal to bristles, but do not
induce ectopic bracts. This result indicates that although E93 expression is normally
restricted to bract cells, this spatial restriction is not essential for normal bract
development. That is, E93 plays a permissive, rather than instructive, role in bract
specification. A very different result was obtained for Pnt: ectopic expression of Pnt at
12-24 hr AP does cause ectopic bract development, indicating that bract position is
defined by spatially restricted pnt activity. These observations suggest that E93 and Pnt
have distinct inputs to Dll activation, with Pnt providing spatial information and E93
providing temporal information. A model for the bract pathway in which Dll is activated
by the combined action of E93 and Pnt is presented in Figure III-14.

The ectopic bracts produced by ectopic Pnt expression are all very near to normal bracts.
Why aren't bracts produced indiscriminately by ectopic Pnt?

Pnt is activated by

phosphorylation as a result of the activity of the EGFR signal transduction pathway.
When Pnt is expressed ectopically, presumably its activity is still restricted to the vicinity
of the normal bracts because only here is it properly phosphorylated. When activity of
the EGFR pathway itself is activated ectopically, bracts are in fact induced everywhere in
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the leg (Fig. III-3 A, del Alamo et al. 2002; Held 2002). An unexpected feature of Pnt
expression is that although Pnt is initially expressed in the bract cells, in later pupae it
becomes partially repressed in these cells and activated in two flanking cells. The basis
of this transition has not been determined. The loss of Pnt expression from the bract cell
may result from repression by E93 or Dll. The activation of Pnt in the two flanking cells
implies that these cells have received EGFR signals, but the origin of these signals is not
clear. As described above, ectopic expression of Pnt in later pupae represses bract
development, suggesting that Pnt may transition from an activator to a repressor of E93
as pupal development proceeds (Fig. III-7 C).

An additional feature established in my work is that bract development is dependent upon
ecdysone signaling. Although I do not know where ecdysone signaling enters into the
bract pathway, it seems likely that it is required for proper E93 expression or activity (see
Fig. III-14).

A second unresolved feature of bract development is that E93 and Dll are activated in
cells that also express the A101 enhancer trap.

This reporter labels sensory organ

precursor cells and their mitotic descendants. Since bracts are clearly not related by
lineage to bristles, the coexpression of A101, E93 and Dll is surprising. One possible
explanation is that A101 expression in bract cells is induced by adjacent A101 positive
cells. Future work will be required to resolve this issue.
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Figure III-14: A model for bract induction
In this model, bristle cell sends out EGFR ligand (green arrow) to activate the EGFR
signaling pathway in an epidermal cell located at the proximal part of the bristle cell.
Thus the activation of EGFR signaling provides the spatial information required for bract
induction. In addition, ecdysone and EcR complex induce E93 expression during
metamorphosis, which provides the temporal information required for bract induction.
The inputs from both Pnt and E93 ensure the activation of Dll at the appropriate time and
space. The green arrow represents the EGFR ligand sent out from the bristle cell. Dotted
lines indicate that other genes are omitted from the pathway.
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Chapter IV : Complementation of the E93Vno alleles and E931, E932, and E933; are
the larval cell death and imaginal patterning functions of E93 executed by different
protein domains?

Abstract
As described in Chapter I, the E93Vno alleles are defective in many imaginal patterning
processes during metamorphosis, whereas the E931, E932, and E933 alleles are defective
in larval cell death during metamorphosis. These two groups of alleles fully complement
one another. To understand this complementation, I first asked whether each allele type
is defective in just one or the other function. Because the E931, E932, and E933 alleles all
cause death prior to imaginal disc differentiation, I assessed their effects on imaginal
patterning by generating homozygous mutant clones. All of these alleles produce normal
cuticular patterns in clones, indicating they all are fully functional in imaginal patterning.
Eric Baehrecke's group has examined larval cell death in hemizygotes for the E93Vno
alleles: all show near normal salivary gland cell death early in metamorphosis. Why do
the two groups of alleles affect specifically one function or the other? The imaginal
patterning function presents few problems; E931 is associated with a nonsense change at
codon 995, and likely complements the E93Vno alleles because the large N-terminal
fragment of E93 it encodes is sufficient to execute all imaginal patterning functions.
Sequence changes have not been identified for E932 and E933 (Lee et al. 2000), but
heterozygotes for these alleles and E93Vnoe47 show almost normal E93 expression in
imaginal tissues, suggesting that these alleles affect regulatory regions specific for larval
cells. In contrast, the ability of the E93Vno alleles to drive larval cell death has been
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difficult to rationalize. These alleles truncate the E93 coding sequence N terminal to
E931, and encode E93 fragments lacking all or part of the pipsq DNA-binding domain. I
have considered two explanations. First, the activation of larval cell death may require
only a specific domain within the E93 protein. To test this possibility, I generated UAS
constructs that express fragments of the E93 (see below). Second, larval cell death may
be activated by previously undescribed products of the E93 locus. This possibility is
explored in Chapter V.

Rationale
The complementation of the E93Vno alleles and E931, E932, and E933 has been difficult to
explain. In this chapter I show that the E931, E932, and E933 alleles affect larval cell
death specifically, and are fully capable of executing the imaginal patterning functions of
E93. Conversely, the E93Vno alleles are defective in imaginal patterning, but are almost
fully capable of executing the larval cell death functions of E93 (Dutta and Baehrecke,
personal communication). Although it is easy to rationalize why the E931, E932, and
E933 alleles are able to function in imaginal patterning, it has been difficult to understand
why the E93Vno alleles are able to function in driving larval cell death. One possibility is
that only a portion of the E93 protein is required for the cell death function. In this
chapter, I test this possibility by driving ectopic expression of subfragments of E93.

Methods
The generation of E93 UAS constructs
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I designed six E93 UAS constructs: UAS-ORF, UAS-Clone2, UAS-E931Nterm, UASE93Vnoe47Nterm, UAS-E93Vnoe47Cterm, and UAS-Δpipsq (Fig. IV-1). All fragments were
amplified from “LP library F211 pBluescript SK-” (the Clone2 cDNA I obtained from
cDNA screening - see Chapter V). Primers were designed so that a consensus translation
initiation sequence in Drosophila (CAAC) was present at the beginning of each ORF.
Each

E93

fragment

was

subcloned

into

PCR8/GW/TOPO

entry

clone

by

PCR8/GW/TOPO TA cloning kit (Invitrogen, Cat # k2500-20), and then recombined into
pTW destination vector for injection (primers used to generate each fragment and
sequence information for each fragment is included in the Appendix). The UAS-LP0
construct was constructed by Dianne Duncan using the pUAST vector. The UASE93(Baehrecke) construct was made by Eric Baehrecke, and was cloned into the pUAST
vector (Lee et al. 2000).

UAS-E93(Baehrecke): E93 full length ORF from Dr. Eric Baehrecke. Although my
sequencing shows that the normal initiating ATG is absent from this construct,
antibody staining (see below) indicates that this construct is translated, presumably
using an alternate ATG.
UAS-ORF: E93 full length ORF
UAS-Clone2: E93 full length ORF with leading sequence of clone2
UAS-LP0: LP0 full length ORF with leading sequence of LP0
UAS-E931Nterm: E93 ORF truncated at the position of the E931 nonsense mutation
(codon 995)
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UAS-E93Vnoe47Nterm: E93 ORF truncated at the position of E93Vnoe47 nonsense mutation
(codon 360)
UAS-E93Vnoe47Cterm: E93 ORF starting from the first in frame ATG after the E93Vnoe47
mutation (codon 371 )
UAS-Δpipsq: E93 ORF with a deletion of codons 750-898. This deletion removes the
pipsq DNA-binding domain (codons 761-814) and surrounding sequences.

The

deletion is bigger than the conserved pipsq domain because of my miscalculation

E93Vnol(3)ry93

E93Vnoe47 E93Vnoe31 E93Vnoe18

E931
E93
LP0
Clone2
UAS-E93(Baehrecke)
UAS-ORF
UAS-clone2
UAS-LP0
1

UAS-E93 Nterm
UAS-E93

Vnoe47

UAS-E93

Vnoe47

Nterm
Cterm

UAS-Δpip
E93 antigen I-III

I

II

III

Figure IV-1: Molecular map of E93 transcripts, mutants, UAS-E93 constructs and
E93 antigen
The boxes represent exons, and shaded areas represent the predicted coding regions. The
transcript inferred by Baehrecke is in red, the LP0 transcript is in green, and the Clone2
transcript is in yellow. Black arrows indicate the stop codon positions of the E93Vnoe47,
E93Vnoe31, E93Vnoe18, and E931 mutations, respectively. The black triangles are insertions
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of two Doc elements and a P-element in the E93Vnol(3)ry93 allele. The E93 UAS constructs
are indicated in gray. Coding regions used for antibody production are in blue.

Stock construction:
I built two groups of stocks. In one group, I included a Gal4 driver (dpp-Gal4, fkh-Gal4,
or act>y+>Gal4), a temperature-sensitive Gal4 repressor (tub-Gal80ts), a clone marker
(UAS-GFP), and E93Df. In the other group, I included one of the UAS-E93 constructs
together with E93vnoe47 or E931.
Gal4 driver stocks
fkh-Gal4

w; tub-Gal80ts UAS-GFP; fkh-Gal4 E93Df /TM6B

dpp-Gal4

w; tub-Gal80ts UAS-GFP; dpp-Gal4 E93Df/TM6B

act>y+>Gal4

yw FLP; act>y+>Gal4 UAS-GFP; tub-Gal80ts
E93Df/TM6B

E93 UAS construct stocks
UAS-E93 (Baehrecke)
UAS-E93-ORF (line A1)
UAS-E93-clone2 (line B2)

w; UAS-E93-X; E93e47/TM6B

UAS-E93-LP0 (line I2e)
UAS-E931Nterm (line D1)
UAS-E93Vnoe47Nterm (line H1)

w; UAS-E93-X; E931/TM6B

UAS-E93Vnoe47Cterm (line A2)
UAS-E93-Δpip (line A3)
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Other stocks and methods:
Clones homozygous for E931, E932, or E933 were generated by crossing y w FLP122;
FRT82B CD2 y+ M(3)W Bsb / TM6B ♀ with FRT82B cu E931/2/3 ca / TM6B ♂, and then
heat shocking progeny larvae at 37̊C for 30min. Homozygous E93 -mutant clones were
identified in non-Tubby progeny and were recognized by their long bristles in both ♀ and
♂, or by their long bristles and yellow cuticle in ♂ flies.

Acridine Orange Staining: imaginal discs are stained in 1.6 uM freshly prepared Acridine
Orange solution for 5 min, rinsed with Ringer’s solution, and mount in Ringer’s solution
for immediate examination.

Results:
E93Vno alleles and E931/2/3 alleles are normal in the function that is defective in the other
complementation group
As described above, the E93Vno mutants are defective in numerous imaginal patterning
processes that take place during metamorphosis. Since homozygotes for E931, E932, or
E933 die at the early pupal stage, I assessed the ability of these mutants to execute
imaginal patterning by generating homozygous mutant clones. All three alleles show
normal patterning in such clones: no patterning defects are found in the leg, the eye, the
antenna, the arista or the abdominal tergites (Fig. IV-2 B-E), all of which show abnormal
phenotypes in the E93Vno mutants. These findings demonstrate that E931, E932, and E933
are not defective in the imaginal patterning functions of E93.
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Figure IV-2: E931/2/3 alleles are normal in imaginal patterning function
A: An E93Vnoe47 mutant clone; this is a positive control to show that there are no bracts in
E93Vnoe47 mutant clones; B-E: E931 mutant clones in the leg, eye, antenna, and abdomen;
Clone boundaries in A, B, C, and E are indicated in red. The red arrow in D indicates an
E931 antenna; the other antenna is heterozygous for the markers M(3)w and Bsb, which
cause a reduction in bristle size and in the aristal branches. E932 and E933 clones behave
identically.

Baehrecke's group has shown that the E931, E932, and E933 mutants are all defective in
the death of larval cells in the midgut and salivary gland during metamorphosis (Lee et al.
2000). In wild-type pupae, salivary glands are completely degraded by 24hr AP, whereas
in hemizygotes for E931, E932, or E933, salivary glands remain intact at this time (Table
IV-1, personal communication from Baehrecke’s lab). For her thesis work, Sudeshna
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Dutta (a graduate student in Eric Baehrecke's lab) examined salivary gland death in
selected E93Vno genotypes. Her results are reproduced in Table IV-1. Hemizygotes for
the E93Vnoe31 and E93Vnoe18 alleles show mildly impaired salivary gland death, with 90 100% of 24 hr AP pupae showing absence or fragmentation of salivary glands. Curiously,
the three heterozygous combinations of the E93Vno alleles and the one homozygote
examined (E93Vnoe31/E93Vnoe31) show a more severe phenotype, with no pupae showing
complete loss of salivary glands at 24 hr AP, 29%-66% showing salivary gland
fragmentation, and 34 - 71% showing intact salivary glands. The weak phenotypes seen
in hemizygotes indicate that the E93Vno alleles are only weakly impaired in the cell death
function, but the stronger phenotypes shown by the homozygous or heteroallelic
genotypes suggest that the E93Vno alleles encode proteins that actively interfere with the
cell death function.

Table IV-1: The percent of 24 hr AP pupae with the indicated salivary gland
phenotypes
(n> 20 pupae/genotype) (personal communication from Sudeshna Dutta and Dr. Eric
Baehrecke)
Intact/condensed

Fragmented

salivary glands

salivary glands

E93Vnoe18/+

0

20

80

E931/Df

100

0

0

E93Vnoe18/Df

10

40

50

Genotype

No glands
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E93Vnoe31/Df

0

35

65

E931/E93Vnoe18

13

20

67

E93Vnoe18/E93Vnoe31 71

29

0

E93Vnoe31/E93Vnoe47 54

46

0

E93Vnoe47/E93Vnoe18 34

66

0

E93Vnoe31/E93Vnoe31 36

64

0

E93 expression in complementing heterozygotes:
The larval midgut
E93Vno/Df animals (E93Vnoe18/Df , E93Vnoe31/Df, and E93Vnoe47/Df) show a strong reduction
in E93 staining in the midgut around 1-5hr AP(Fig. IV-3 B, C, D), despite showing nearnormal salivary gland apoptosis (personal communication from Baehrecke’s lab).
E931/Df, E932/Df, and E933/Df animals also show a strong reduction in E93 staining in
the 1-5 hr AP midgut (Fig. IV-3 E, F, G). I also examined E93 staining in heterozygotes
for the E93Vnoe47 allele and E931, E932, and E933. E93Vnoe47/E931 heterozygotes show
very little E93 staining in the 1-5 hr AP midgut. In contrast, almost normal E93 staining
is seen in the 1-5 hr AP midgut in E93Vnoe47/E932 and in E93Vnoe47/E933 heterozygotes
(Fig. IV-3 I, J). The latter results are striking because neither E93Vnoe47 nor the E932 or
E933 mutants show much staining in midgut cells on their own when hemizygous. One
possibility is that E932 and E933 are mutations in larval-cell specific enhancer(s), and that
the normal larval enhancers carried by the E93Vnoe47 allele can act in trans to activate
expression of the intact E93 coding region from the E932 and E933 alleles. Such trans
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action of enhancers (transvection) has been described for several other genes in
Drosophila. Although transvection may help account for the ability of the E93Vno alleles
to complement E932 and E933, transvection cannot explain the complementation of these
alleles with E931, nor can it explain why the E93Vno alleles are able to execute nearnormal larval cell death on their own.

Imaginal patterning
The ability of the E932 and E933 alleles to execute the imaginal patterning functions of
E93 is consistent with the expression of E93 protein in heterozygotes of these alleles and
E93Vno alleles. E93Vno/Df animals (E93Vnoe18/Df , E93Vnoe31/Df, and E93Vnoe47/Df) show a
strong reduction in E93 staining in bract cells in pupal legs (Fig. IV-3 B’, C’, D’).
However, E932/E93Vnoe47 and E933/E93Vnoe47 heterozygotes show almost normal levels of
E93 expression in bract cells (Fig. IV-3 I’, J’). This result suggests that the E932 and
E933 mutations may be defective specifically in larval cell expression. The E931 allele (a
nonsense change at codon 995) behaves differently: E931/E93Vnoe47 heterozygotes show
some staining of E93 in pupal legs, but it is not as strong as in E932/E93Vnoe47 or
E933/E93Vnoe47 heterozygotes (Fig. IV-3 H’). One possibility is that the large N-terminal
fragment encoded by E931 is competent to execute the imaginal patterning functions of
E93, even when present at low levels.
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Figure IV-3: Expression of E93 in different allelic combinations during
metamorphosis
A-J: Midgut at 1-5hr AP; A’-J’: Pupal leg at 30-50hr AP; A & A’: Wild-type; B & B’:
E93Vnoe18/Df; C & C’: E93Vnoe31/Df; D & D’: E93Vnoe47/Df; E: E931/Df; F: E932/Df
(coming soon); G: E933/Df; E, F and G genotypes were not survive to late pupal stage, so
E’, F’ and G’ are Not Available (N/A); H &H’: E93Vnoe47/E931; I & I’: E93Vnoe47/E932; J
& J’: E93Vnoe47/E933.

The execution of imaginal patterning function and larval cell death function
Generation of UAS constructs
To test whether specific subdomains of E93 are responsible for the imaginal patterning
and cell death functions of the locus, I generated UAS constructs that express fragments
of the E93 coding sequence (see Methods).

I also generated constructs expressing

alternate transcripts from the locus. The molecular maps of the UAS constructs I
examined are summarized in Fig. IV-1. To make sure that the constructs I produced are
capable of being expressed, I tested each transformant line by crossing it to en-Gal4 and
staining the progeny embryos for E93 expression. All eight constructs analyzed produce
striped embryos, indicating that the constructs are correct and have been engineered into
transformants successfully (Fig. IV-4).
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Figure IV-4: Expression of E93 UAS constructs in embryos when driven by en-Gal4
A: UAS-E93(Baehrecke); B: UAS-ORF A1 line: C: UAS-clone2 B2 line; D: UAS-LP0
I2e line; E: UAS-E931Nterm D1 line; F: UAS-E93Vnoe47Nterm H1 line; G: UASE93Vnoe47Cterm A2 line; H: UAS-Δpipsq A3 line; A-H are all stained by E93 antibody
from rabbit B, except F, which is stained by E93 antibody from mouse 5.

Imaginal patterning function
My work to test the ability of the UAS constructs to rescue the imaginal patterning
functions of E93 has only just begun. The one result I have is described in Chapter III: in
this experiment I showed that clones expressing the UAS-ORF construct during pupal
development in E93Vnoe47 mutants are able to rescue bract formation proximal to bristles
in the legs, but do not cause additional cells in the leg to become bracts (Fig. III-13).
This observation demonstrates that E93 plays a permissive rather than instructive role in
bract formation. Tests of the rescue ability of the other UAS constructs are in progress.
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Larval cell death function
It has been difficult to understand why the E93Vno mutants are almost fully competent to
drive larval cell death. All three of these mutations are nonsense alleles that truncate the
coding sequence N-terminal to the E931 allele, which is defective in larval cell death.
They also lie N-terminal to the pipsq DNA binding domain. One possibility is that the
portion of the protein N-terminal to the 5'-most of the E93Vno truncations (E93Vnoe47) is
capable of executing the cell death function.

Another possibility is that translation

reinitiation occurs subsequent to termination at the E93Vno nonsense changes, so as to
produce C-terminal fragments of E93 capable of executing the cell death function.

As an initial test of these possibilities, I drove expression of each UAS construct using
fkh-Gal4, which is expressed in salivary glands in the embryo and larva (Henderson and
Andrew 2000; Berry and Baehrecke 2007). Although there was some variation among
different lines tested for each construct, in general, each construct had a consistent effect.
The results are summarized in Table IV-2. Salivary glands were absent in late larvae
when fkh-Gal4 was combined with the full length variants UAS-ORF, UAS-Clone2, and
UAS-LP0. Expression of the full-length construct UAS-E93 (Baehrecke) did not cause
ablation of salivary glands, but I have shown that this construct has an introduced
mutation in its initiating ATG.

Among the partial E93 constructs tested, UAS-

E931Nterm and UAS-E93Vnoe47Cterm caused deletion of salivary glands, but UASE93Vnoe47Nterm and UAS-E93-Δpipsq did not. If we assume that larval salivary gland
ablation is a good proxy for the larval cell death function of E93, then the finding that
UAS-E93Vnoe47Nterm does not affect salivary glands argues that the normal larval cell
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death seen in E93Vnoe47 mutants is not due to activity of the N-terminal nonsense fragment
encoded by this mutation. The finding that UAS-E93Vnoe47Cterm does cause deletion of
salivary glands suggests that larval cell death in E93Vnoe47 mutants may be executed by a
C-terminal fragment of E93 produced by translation reinitiation. The finding that UASE931Nterm causes salivary gland ablation was surprising because salivary gland death is
defective in E931 mutants, which presumably produce this fragment endogenously. A
likely explanation is that this fragment is produced at higher levels in fkh-Gal4/UASE931Nterm heterozygotes than in E931 mutants. The complete lack of effect of UASE93-Δpipsq suggests that the DNA-binding pipsq domain is essential for the cell death
functions of E93.

Table IV-2: The effects of UAS-E93 constructs when expression driven by fkh-Gal4
Observed salivary gland
UAS-E93 (Baehrecke)

present

UAS-ORF

deleted

UAS-E93-Clone2

deleted

UAS-E93-LP0

deleted

UAS-E931Nterm

deleted

UAS-E93Vnoe47Nterm

present

UAS-E93Vnoe47Cterm

deleted
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UAS-E93-Δpipsq

present

However it is not clear that the loss of larval salivary glands is a valid assay for the larval
cell death function of E93. To determine whether E93 can cause death of imaginal cells,
I drove UAS-LP0 by dpp-Gal4 in larvae and used tub-Gal80ts to control the timing of
expression.

Acridine orange staining after 22 hr of expression revealed cell death

induction along the compartment boundaries of the imaginal discs, whereas the wild-type
control group had much less cell death in discs (Fig. IV-5). Thus, it is possible that the
deletion of salivary glands in fkh-Gal4>UAS-E93 constructs is caused by cell death as
well.

Figure IV-5: UAS construct causes cell death in imaginal discs
A: Wild-type wing disc; B: dpp-Gal4>UAS-LP0 expressed in a wing disc for 22hrs; C:
Wild-type leg disc; D: dpp-Gal4>UAS-LP0 expressed in a leg disc for 22hrs; A-D: dppGal4 is repressed by tub-Gal80ts during embryonic and early larval stages, and activated
in 3rd instar larvae. All discs stained with acridine orange.

To look directly for a C-terminal fragment encoded by the E93Vnoe47 mutant, I took
advantage of the antigen specificity of the E93 antibodies produced by Mouse 5 and
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Mouse 6. The Mouse 5 antibody was raised against antigen II, which is in the N-terminal
half of the coding sequence, whereas the Mouse 6 antibody was raised against antigen III,
which is in the C-terminal half (Fig. II-1 I, L and Fig. IV-1). If the larval cell death
function in the E93Vnoe47 mutant is executed by a C-terminal fragment of E93 produced
by translation reinitiation, then this protein should be detected by the antibody from
Mouse 6, but not from Mouse 5. The result was that neither antibody detected any signal
in the 2hr AP midgut or 13hr AP salivary gland (Fig. IV-6 C, D, G, H) of E93Vnoe47
mutants. Even the rabbit antibody raised against all three antigens failed to detect any
signal (Fig. IV-6 B, F). If a C-terminal fragment is produced in the E93Vnoe47 mutant, it is
in amounts below detection by our antibodies.
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Figure IV-6: The relationship of E93 functional domain and the execution of larval
cell death
A-D: 2hr AP midgut; E-H: 13hr AP salivary gland; A, E: Wild-type animal; B-D, F-H:
E93Vnoe47/Df mutant; A, B, E, F: stained using antibody from Rabbit B; C, G: stained
using antibody from Mouse 5; D, H: stained using antibody from Mouse 6.

Discussion
In this chapter I attempt to understand the complementation of the E931, E932, and E933
alleles, which are defective in larval cell death, and the E93Vno alleles, which are
defective in many imaginal patterning processes during metamorphosis. In my work, I
showed that clones of cells homozygous for E931, E932, or E933 show completely normal
imaginal patterning, demonstrating that these alleles are defective only in driving larval
cell death. Conversely, Baehrecke's group has shown that the E93Vno mutants show near
normal larval cell death, indicating that these alleles more or less specifically affect the
imaginal patterning function of E93.

Given that these two groups of alleles affect

different functions of E93, their ability to complement clearly does not require a special
interaction between alleles such as transvection or trans-splicing. Rather, the problem lies
in understanding why the two groups of alleles specifically affect primarily one or other
function.

The requirements for the imaginal patterning function of E93 seem fairly straightforward:
The E93Vno alleles are nonsense changes N-terminal to or within the pipsq DNA-binding
domain, suggesting that imaginal patterning is executed by the E93 protein first defined
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by Baehrecke's group. Antibody stainings suggest that the E932 and E933 alleles express
this protein properly in imaginal tissues, accounting for the ability of these alleles to
complement the E93Vno alleles. The E931 allele likely complements the E93Vno alleles
because the large N-terminal fragment it encodes (which contains amino acids 1 - 994
and includes the pipsq domain) is sufficient to execute the imaginal patterning functions
of E93.

The requirements for the larval cell death function of E93 are much less clear. A major
impediment has been that sequence changes have not been identified for the E932 and
E933 alleles; neither affects the known coding sequences of E93. Possibly, these alleles
affect regulatory sequences required for expression in larval cells. The E931 allele does
affect the coding sequence (it is a nonsense change at codon 995). This allele causes
dramatically reduced expression of E93 in imaginal and larval cells, likely because it
causes nonsense-mediated decay (reviewed in Wen and Brogna 2008) of E93 transcripts.
This reduced expression is likely responsible at least in part for the loss of larval cell
death in this mutant, since expression of the E931 N-terminal fragment driven by the
UAS system causes the ablation of larval salivary glands.

The ability of the E93Vno mutants to execute the larval cell death function is particularly
difficult to explain. My finding that expression of the N-terminal fragment encoded by
the E93Vnoe47 allele does not ablate larval salivary glands suggests that this fragment
cannot drive cell death. My finding that the coding sequence C-terminal to the E93Vnoe47
truncation does cause larval salivary gland ablation suggests that translation reinitiation
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in this mutant might produce an E93 C-terminal fragment capable of driving larval cell
death. However, such a reinitiation product was not identified by antibody staining.
Perhaps the level of protein expression is too low to be detected by our staining, or
translation reinitiation is in a different reading frame, and therefore not detectable by our
antibodies. Taken together, these observations raise the possibility that the larval cell
death function of E93 may be executed by a novel product or products from the locus. In
Chapter V, I describe my search for such products.
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Chapter V : Search for alternate products from E93

Abstract
Northern blotting, RTPCR, cDNA screening, and Ribonuclease Protection Assays (RPA)
were used to search for alternate transcripts of E93 that might function specifically in its
larval cell death or imaginal patterning functions. Northern blotting confirmed the
presence of the 9.5kb E93 transcript described by Baehrecke and Thummel (1995). The
LP0 transcript was also confirmed, but this RNA and the E93 RNA are expressed in both
larval and imaginal cells, indicating neither is specific for imaginal patterning or larval
cell death. I identified a novel E93 transcript (called clone2) by cDNA screening, but it
contains the same coding region as E93. Using probes from the 3' portion of the E93
coding region, I also detected three small polyadenylated transcripts on Northern blots.
These RNAs appear just prior to salivary gland cell death, suggesting they may be
involved in executing larval cell death. However, RPA experiments failed to detect novel
splice sites for these RNAs, suggesting they may be degradation products of the larger
E93 RNAs.

Rationale
In Chapter IV, I showed that the E931, E932, and E933 alleles are able to execute the
imaginal patterning functions of E93 normally, but are defective in larval cell death.
Conversely, the E93Vno alleles are defective in imaginal patterning during metamorphosis,
but can execute the larval cell death function almost normally. One explanation for the
specificity of these two allele types is that they affect alternate products of the locus that
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execute the two functions. In this Chapter, I describe my efforts to identify alternate
products from E93.

Methods
Northern Blots
Pupae were staged by collection of white prepupae. Total RNA was extracted from
larvae or pupae using the TRI Reagent (Sigma Cat# T9424). PolyA mRNA was purified
using the PolyATract mRNA Isolation System IV (Promega Cat# Z5310). All samples
were normalized by their O.D. value (measured using a NanoDrop ND-1000
Spectrophotometer), and stored at -70˚C before use.

RNA samples were separated on 1.5% Agarose (ISCBioExpres Cat# E-3120-500) gels in
2.2 M formaldehyde and 1X MOPS buffer (20mM MOPS pH 7.0, 2mM NaOAc, 1mM
EDTA pH 8.0), transferred to a Nitrocellulose Transfer Membrane (Micron Separations
INC. Cat# E04HY00010), fixed on the membrane by 90 seconds of U.V. irradiation,
incubated with radioactive probes, and exposed to X-ray film to detect signals. For reuse
with other probes, membranes were stripped in 0.1% SDS or Strip-EZTM RNA (Ambion,
Cat# 1360-1368).

Probe sequences were amplified by PCR, purified by MinElute Gel Extraction Kit
(QIAGEN Cat#28604), ligated with the pSTBlue-1 AccepTorTM Vector (Novagen Cat#
70595-4DFRZ), and transformed into NovaBlue SinglesTM competent Cells (Novagen
Cat# 70181-4PKG) or Electrocompetent Cells (Lucigen Corporation, Cat# 60052-4). The
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molecular map of each probe is shown in Fig. V-1. The primers used to generate each
probe are included in the Appendix. For rp49, DNA probes were labeled with

32

P by

Oligolabeling using random primers (Pharmacia Cat# 27-9250-01). DNA probes were
also used for the 1st half of pipsq (P1) and the 2nd half of pipsq (P2); these were labeled
with 32P by PCR (Fig. V-9). All other probes were RNA, and were labeled with 32P by in
vitro transcription from the SP6/T7 promoter (MAXIscript SP6/T7 kit Ambion Cat#
1320). Probes were purified on Sephadex G-50 columns pre-equilibrated with STE (0.1M
NaCl, 10M Tris-Cl, 1mM EDTA pH8.0), and denatured before use.

Densitometry was measured by BIO-RAD Fluor-S MultiImager and normalized by the
background and rp49 loading control in the same lane with equal area. For example, the
normalized-Banddensity = (Banddensity - Backgrounddensity) / (rp49density - Backgrounddensity)

Reverse Transcriptase PCR (RTPCR)
2ug total RNA was used for reverse transcription, which was conducted at˚C44f

or 1

hour, followed by 10 min
˚C 92
heat inactivation of the reverse transcriptase
(RETROscriptTM Kit, Ambion Cat#1710). Reaction without reverse transcriptase was
used as negative control to ensure no contamination from genomic DNA.

5ul of reverse transcription products were used for the next PCR reaction. Different
primers were tested to avoid unwanted side products. The final primers used in RTPCR
are shown in Fig. V-4, sequences are included in Appendix. Different cycle times (20-30
cycles) were tested to ensure that the amount of product was below the saturation. The
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optimized thermocycle profile was: 95°C 4min one cycle; 94°C 0.5min, 61°C 25sec,
72°C 1.5min (1min per kb of target) 30 cycles; 72°C 5min one cycle, 4°C forever.

cDNA screening
The cDNA LP library were constructed from pupal stage RNA using the Uni-ZAP XR
Vector Kit and Uni-ZAP XR Gigapack Cloning Kits. The E93 C-terminal fragment
(5exoIII) was labeled by Oligolabeling (Pharmacia Cat# 27-9250-01) and used to screen
the LP library. Positive clones were purified, and the pBluescript phagemid excised using
the ExAssist Interference-Resistant Helper Phage into the SOLR bacteria strain
(Stratagene Cat#200253). The pBluescript phagemid clones were stored in glycerol stock
at -80˚C. The molecular map of identified cDNA clones are shown in Fig. V-9. Their
sequences are included in the Appendix.

Ribonuclease Protection Assay (RPA)
RNA probes were labeled by in vitro transcription (MAXIscript SP6/T7 kit, Ambion
Cat# 1320). RNA samples were hybridized with RNA probes and digested by RNase
A/RNase T1 Mix (RPA IIITM kit, Ambion Cat# 1415). Samples were separated in 6%
acrylamide. Signals were detected by X-ray film.

Results
Northern blotting
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E93Vnol(3)ry93
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P1 P2

Figure V-1: The molecular map of probes used in Northern blots
The green and red boxes represent LP0 and E93 transcripts respectively. The shaded
areas represent the predicted ORFs. The dashed lines in E93 represent omitted sequences.
The relative positions of E93Vnoe47, E93Vnoe31, E93Vnoe18 and E931 are indicated above the
transcripts. The E93Vnol(3)ry93 is inserted before the 1st exon of E93, and between the 3rd
and 4th exon of LP0. The grey boxes are the probes used in Northern blots. LP0 US (LP0
unique start) is specific to LP0 (grey box with green outline). E93 US and AccI fragment
are specific to E93 (grey boxes with red outline). The other probes come from shared
common exons of LP0 and E93. The P1 (the 1st half of pipsq) and P2 (the 2nd half of
pipsq) probes are DNA probes, all the other probes are RNA probes (rp49 DNA probe is
not included in this picture, because it is from a different gene).

I first examined the expression profile of E93 by Northern blotting. Baehrecke and
Thummel (1995) detected a 9.5 kb transcript using an AccI fragment from the E93 3'
UTR as probe. I confirmed this result and found a similar expression profile: the 9.5 kb
transcript is expressed at 12hr AP and disappears by 48hr AP in wild-type total RNA
probed by AccI RNA probe (Fig. V-2). The same result was obtained when the RNA
probe from the 5' unique start region of the LP0 transcript (LP0 US) was used (Fig. V-2).
The lower band visible in the LP0 US blot is probably ribosomal RNA (Fig. V-2). When
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the RNA probes from the 5' start region unique to E93 (E93 US) or the E93 ORF Minus
the Unique Start (E93 ORF MUS) were used, a heavy smear is detected, probably due to
the presence of repetitive regions in these probes (Fig. V-2).
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Figure V-2: The expression profile of wild type Total RNA probed by AccI, LP0 US,
E93 US, and E93 ORF MUS
Total RNA of wild-type staged pupae (0-48hr AP) was extracted and 40ug total RNA
was loaded per lane. RNA probes of AccI, LP0 US, E93 US, and E93 ORF MUS
fragments were used to probe the blots.

The LP0 and E93 transcripts show no tissue specific distribution
The P-element insertion in the allele E93Vnol(3)ry93 lies 5' to the E93 transcript, and within
an intron of the LP0 transcript (see Fig. V-1, Fig. IV-1). This allele is defective in the
imaginal patterning function of E93 but does not appear to affect the cell death function.
We wondered whether this allele might specifically affect expression of the LP0
transcript. The P-element in the E93Vnol(3)ry93 insertion carries rosy+ (ry+) as a marker.
The ry+ fragment in this element includes a portion of an adjacent gene, l(3)S12. When
inserted within an intron, this fragment of l(3)S12 can act as a splicing acceptor and
transcriptional terminator (Horowitz and Berg 1995). Thus, one might expect the l(3)S12
insertion to cause truncation of the LP0 transcript, but to have no effect on the E93 RNA.
Such a finding would support the model that the LP0 transcript is responsible for the
imaginal patterning functions of E93, while the E93 transcript is responsible for its cell
death functions. Surprisingly, when LP0 US was used as an RNA probe, E93Vnol(3)ry93
homozygotes showed a 9.5kb band, as in wild type, indicating that termination does not
always occur within the insertion. Bands of 5kb and >9.5 kb are also present (Fig. V-3).
To determine whether any of these bands contained l(3)S12 sequences, the blots were
reprobed with l(3)S12 RNA probe. This probe detects the 9.5 kb and >9.5 kb bands plus
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a new band at ~6kb, but did not detect the 5kb band, whose origin remains unexplained
(Fig. V-3). None of these bands are endogenous l(3)S12 transcripts, as these are only
0.7kb in size.

Figure V-3: The expression profile of wild type and E93Vnol(3)ry93 mutant
Total RNA of E93Vnol(3)ry93 and wild-type staged pupae (0-45hr AP) was probed by LP0
US and l(3)S12 RNA probes. P/P represents E93Vnol(3)ry93 homozygotes; P/+ represents
E93Vnol(3)ry93 heterozygotes; +/+ represents wild-type. 40ug total RNA per lane.
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#3

#2 #1
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(

985 bp

#3

)
#2 #1

Figure V-4: The molecular map of primers used in RT PCR
The LP0 and E93 transcripts are as described in Fig. V-1. The arrows below the LP0 and
E93 cDNA are the primers used in RTPCR. The sizes of expected RTPCR products are
indicated in the parentheses.

To determine whether the E93Vnol(3)ry93 P-element sequences are ever correctly spliced out
of the mature LP0 transcript, we performed RTPCR to amplify transcript sequences
spanning the insertion site. As indicated in Fig. V-4, a primer complementary to the end
of the third common exon of E93 and LP0 was used to prime reverse transcription (the
black arrow labelled #1 in Fig. V-4; the sequences of this and all other primers are
included in the Appendix). PCR was then carried out using a 5' primer specific for the
LP0 transcript (the green arrow #3) and an internal backward primer (the black #2 arrow).
PCR was also carried out using a 5' primer specific for the E93 transcript (the red arrow
#3) and the internal backward primer (black arrow #2). The PCR products for LP0 and
E93 are distinguishable by size (985bp for LP0, 916bp for E93). We were surprised to
find that E93Vnol(3)ry93 mutant homozygotes produce normal sized RTPCR products for
LP0 (Fig. V-5). These products were sequenced and no differences were found relative
to the same PCR products from wild type. This observation indicates that the P and Doc
elements do not cause strong transcriptional termination and are correctly excised from
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the LP0 transcript in the E93Vnol(3)ry93 mutant.

I also used RTPCR to examine the

expression profiles of LP0 and E93. These experiments show that in wild type LP0 is
weakly expressed at 0hr AP, increasing gradually from 9-45hr AP, whereas E93 is
expressed robustly all the way through the period 0-45hr AP (Fig. V-5, whole animal
+/+). In E93Vnol(3)ry93 homozygotes, LP0 expression is weak in 0-18hr AP, and increases
from 27-45hr AP; E93 is present in all stages (Fig. V-5, whole animal P/P). Compared to
wild type, E93Vnol(3)ry93 homozygotes show a delay in expression of LP0 and may show an
overall reduction in expression of LP0 and E93. I also used RTPCR to examine the tissue
specificity of LP0 and E93 expression (Fig. V-5). The results indicate that both LP0 and
E93 are expressed in both imaginal discs and salivary glands. Taken together, my results
argue against the hypothesis that the LP0 transcript is responsible for the imaginal
patterning function of E93 or that the E93 transcript functions specifically to drive larval
cell death.
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Figure V-5: RTPCR of wild type and E93Vnol(3)ry93 mutant.
P/P represents E93Vnol(3)ry93 homozygotes; P/+ represents E93Vnol(3)ry93 heterozygotes; +/+
represents wild type.

Three small transcripts detected by Northern blotting
To look for additional alternate transcripts, I returned to Northern blotting. Instead of
using the entire coding region as probe, which produces a heavy smear, we dissected the
coding region into smaller fragments and used these as probes on blots of total and
polyA+ RNA from wild type. Two RNA probes from the C-terminal region of the
coding sequence (the Pipsq probe and 5exoIII probe see Fig. V-1) provided striking
results. These probes detected three strong bands of 1.7kb, 1.4kb and 0.6kb in RNA from
pupae at 9hr AP (Fig. V-6). These bands are detectable in total RNA, but are strongly
enriched in polyA+ RNA (Fig. V-6). The 5exoI and LP0 US probes appear to detect very
weakly these same bands. Other fragments from the ORF detected smeary patterns, with
bands of 2.5kb and 4kb visible in polyA+ RNA blots (Fig. V-6).
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Figure V-6: The expression profile of wild type Total RNA and PolyA+ RNA probed
by Pipsq, 5exoIII, LP0 US, E93 5exo I, E93 US, E93 234exo, and E93 5exoII.
L represents 3rd instar larvae; 0, 9, 18 represent 0-18hr AP. 5ug Total RNA or 0.5ug
PolyA+ RNA per lane.

I then used the pipsq probe to check the expression of these small transcripts throughout
the period from late third instar larva to 48hr AP in 3 hr intervals. In this period, these
RNAs appear only around 9 hr AP (Fig. V-7). Northern blotting of samples taken every
half hour from 6.5 hr to 11 hr AP shows that the small transcripts are induced at 7AP and
disappear by 11AP (Fig. V-7).
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Figure V-7: The expression profile of three small transcripts in WT animal
L represents larvae, numbers above the lanes represent 0-48hr AP, 5ug Total RNA per
lane

One or more of the 1.7kb, 1.4kb and 0.6kb transcripts might be responsible for the cell
death functions of E93. There are four reasons to suspect such a role: first, these RNAs
include the C-terminal region of E93 where the E931 allele is located. Second, these
RNAs do not appear to contain most sequences from the N-terminal portion of E93,
where the E93Vno alleles are located. Third, these RNAs are produced just prior to
salivary gland cell death. Fourth, the transcripts detected by the C-terminal probes are
below the size cutoff of most cDNA libraries, perhaps accounting for why they have not
been detected previously.

If the small RNAs are responsible for the cell death function of E93, one might expect
their levels or size to be affected by alleles that are defective in this function. As a
control, I first used 5exoIII to probe Northern blots of RNA from wild-type hemizygotes
and wild-type homozygotes. All three bands showed a reduction in intensity by about
half in hemizygotes (Fig. V-8 A), suggesting that the small RNAs are encoded by the E93
locus and are not being detected by cross hybridization. I then examined E931, E932, and
E933 mutant hemizygotes. The three small RNAs are reduced in these three genotypes
relative to wild type, but no more than expected from the hemizygosity of the locus (Fig.
V-8 B). The E93Vnoe31 and E93Vnoe47mutants also showed small reduction in upper and
middle bands (Fig. V-8 C, D), but E 93Vnoe18 and E93VnoPry93 showed similar intensity
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compared with wild type (Fig. V-8 E, F).

The Tp(3;3)Vno mutants showed a smeary

pattern (Fig. V-8 G).
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Figure V-8: The reduction of small RNA transcripts in E931/2/3 mutants, E93Vno
mutants, and wild-type hemizygotes
rp49, a ribosomal protein gene, was used as loading control (prepared as DNA probe by
Oligolabeling using random primers). The right panel shows the densitometry of the three
small bands after normalization. Wild type and the mutants are color coded as indicated
above the lanes. 5ug Total RNA or 0.5ug PolyA+ RNA per lane.

I also used sub-fragments of the E93 pipsq probe to see whether these bands are specific
to a smaller region. The 1st half of pipsq DNA probe (P1 in Fig. V-1) did not detect any
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signal after 98hr exposure (Fig. V-9 A). The 2nd half of pipsq DNA probe (P2 in Fig. V-1)
detected the two smaller bands (Fig. V-9 B).

Figure V-9: Authenticity test of the three small transcripts by subfragments of
pipsq probe
A: Wild-type 9hr AP PolyA+ RNA (0.5ug) probed by the 1st half of pipsq DNA probe; B:
Wild-type 9hr AP PolyA+ RNA (0.5ug) probed by the 2nd half of pipsq DNA probe; C &
D: The blots used in A & B were stripped and reprobed by pipsq RNA probe to confirm
the RNA sample is still intact.

To determine whether RNAs were transcribed from the sense strand of pipsq and 5exoIII,
I used sense strand RNA probes from these regions to probe Northern blots. The sense
strand of 5exoIII did detect a small RNA after 4hr exposure (Fig. V-10 B). However, the
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sense strand of pipsq did not detect any obvious band, even after 20hr exposure (Fig. V10 C).

Figure V-10: Authenticity tests of the three small transcripts by sense strand RNA
probes
A: The wild-type 9hr AP Total RNA (5ug), PolyA- RNA (5ug), and PolyA+ RNA (0.5ug)
probed by pipsq RNA probe; B: The blot used in A was stripped and reprobed by 5exoIII
sense strand RNA probe; C: the blot used in A and B was stripped and reprobed by pipsq
sense strand RNA probe.

Attempt to identify the three small transcripts by RPA
The three small RNAs that appear at 9 hr AP suggest that novel splice sites may be
present in the 3’ portion of the E93 coding sequence. To search for such sites, I used the
Pipsq and 5exoIII probes in Ribonuclease Protection Assays (RPA). When I used the
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pipsq probe, I saw two small protection bands in Total and PolyA- RNA lanes, but not in
PolyA+ RNA (Fig. V-11 lane 3-5). Since Northern blotting indicates that the three small
transcripts are enriched in PolyA+ RNA (see above), it seems unlikely that the protected
bands represent these transcripts. No specific protection was detected for the 5exoIII
probe (Fig. V-11 lane C-E). A probe covering the boundary of E93 5exon (which protects
the first 240bp of E93 5exon) was used as a positive control to ensure the RPA assay was
working properly (data not shown).

Figure V-11: RPA assay
The blot on the left was probed by Pipsq, the blot on the right by 5exoIII; Lane 1 and A
are RNA ladders; Lane 2 is Yeast RNA (2ug) plus Pipsq probe (560bp expected); Lane 3
is Pipsq protected by Fly 9 hr AP Total RNA (25ug) (445bp expected); Lane 4 is Pipsq
protected by Fly 9 hr AP PolyA- RNA (30ug); Lane 5 is Pipsq protected by Fly 9 hr AP
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PolyA+ RNA (1.8ug); Lane B is the 5exoIII probe plus Yeast RNA (2ug) (904bp
expected); Lane C is 5exoIII protected by Fly 9 hr AP Total RNA (20ug) (802bp
expected); Lane D is 5exoIII protected by Fly 9 hr AP PolyA- RNA (20ug); Lane E is
5exoIII protected by Fly 9 hr AP PolyA+ RNA (1ug). The origin of the two small bands
(~150 bp and ~350 bp) in lanes 3&4 is not known, but is unlikely to be due to the small
RNAs detected by Northern blotting.

cDNA screening for additional alternate transcripts
As a second approach to identifying alternate transcripts, I screened a fly cDNA library
constructed from pupal stage RNA (the LP library) using a C-terminal fragment (5exoIII)
as probe. I recovered 6 clones, but none are alternatively spliced and all are at least 2kb
long (Fig. V-12, white boxes, detailed sequence information is available in Appendix).
However, I did make two new discoveries. First, I found two new 5’ exons in clone 2. In
genomic DNA, these exons extend 3.2kb upstream of the E93 transcript and 1.7kb
upstream of the E93Vnol(3)ry93 insertion. Second, all six clones end at the same place,
300bp downstream of the ORF, suggesting that most E93 transcripts do not contain the
large 3' UTR present in the 9.5kb E93 transcripts.

E93Vnol(3)ry93

E93Vnoe47 E93Vnoe31 E93Vnoe18

E931
E93
LP0

Clone 1
Clone 2
Clone 3
Clone 5
Clone 6
Clone 7
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Figure V-12: The molecular map 6 clones discovered from cDNA screening.
The LP0 and E93 transcripts are as described in Fig. V-1. The white boxes are the 6
clones identified from cDNA screening. Clone 2 has two novel exons presented by grey
boxes.

Discussion
In this chapter, I search for alternate products of E93 that might be responsible for its
larval cell death and imaginal patterning functions. Northern blotting confirmed the 9.5kb
E93 transcript described by Baehrecke and Thummel (1995) and provided a profile for its
expression. Probes specific for the LP0 transcript also detect RNAs of 9.5 kb. The LP0
transcript appeared initially to be a good candidate for executing the imaginal patterning
functions of E93. E93Vnol(3)ry93 is a Vno-type allele associated with the insertion of a P
element and two Doc elements within the third intron of the LP0 transcript, just upstream
of the E93 transcript. The P-element in the E93Vnol(3)ry93 mutant carries a fragment of
l(3)S12 that in other contexts causes termination of transcription (Horowitz and Berg
1995).

Therefore, an attractive model was that premature termination of the LP0

transcript in this allele was responsible for its effects on imaginal patterning. However,
to my surprise, I found that the LP0 transcript is not eliminated in the E93Vnol(3)ry93 mutant,
indicating that transcriptional termination by the l(3)S12 sequence does not occur in this
context, or occurs with low efficiency. In addition, RTPCR experiments demonstrated
that the P and Doc sequences are correctly excised from the E93 primary transcript.
RTPCR experiments also demonstrated that the LP0 and E93 transcripts are expressed in
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both larval and imaginal tissues, arguing against the possibility that either specifically
executes the larval cell death or imaginal patterning functions of E93.

Northern blots also demonstrated the existence of three small transcripts in PolyA+ RNA
(Fig. V-6, Fig. V-7). These are good candidates for the larval cell death function of E93,
as they appear just prior to salivary gland death and are detected by the 3' portion of the
coding sequence, near where the E931 allele is located. Attempts to identify these RNAs
by RPA were inconclusive; no novel splice sites were detected using the pipsq and
5exoIII regions of the E93 coding sequence as probes (Fig. V-10). The small RNAs may
be degradation products of E93 produced during apoptosis and their functions, if any,
may be unrelated to cell death.

Besides the three small RNAs, transcripts of 2.5kb and 4kb were detected by many
probes (E93US, 234exo, 5exoI, 5exoII, and 5exoIII, Fig. V-6). Although these bands are
variable in intensity, they are very robust compared with the original 9kb band detected
by the 3' AccI probe, suggesting that some E93 transcripts may not contain the long 3’
UTR region. In an attempt to identify these potential alternate transcripts, I screened for
additional cDNAs using 3' coding sequences as probe. Of six cDNAs identified, one
(clone2) has a novel 5' exon, but it contains the same coding region as E93.
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Chapter VI : Future directions

The study of the role of E93 in imaginal patterning during metamorphosis promises to
provide important insights into how stage-specificity is achieved during development.
Here are some questions I think future work should be directed toward answering:

A. How does E93 regulate Dll expression? I have shown that Dll lies downstream of E93
in the bract pathway, but we do not know whether E93 regulates Dll through direct
binding or through other genes and/or cofactors. Identification of the Dll bract enhancer
and study of its interaction with E93 and Pnt is a high priority, and could serve as a
model for understanding how E93 provides temporal specificity during metamorphosis.

B. Where in the bract pathway does ecdysone signaling act? So far, clones that are
knocked down for the ecdysone receptor have failed to show any effect on E93
expression in bract cells. Clones having a more severe knockdown of receptor activity,
either usp mutant clones or EcR RNAi clones, need to be generated to test whether
ecdysone signaling is required for E93 expression in bract cells and other imaginal tissues.
If ecdysone does not control imaginal expression of E93, then it will become a key to
determine whether EcR interacts directly with the Dll bract enhancer and/or with Pnt.

C. Are distinct domains of E93 involved in executing the imaginal patterning and larval
cell death functions of E93? I have generated stocks which should allow testing the
abilities of portions of E93 to rescue the cell death and imaginal patterning functions of
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E93. These experiments could provide an explanation for the different phenotypes of the
Vno and cell-death alleles of E93.

D. What is the relationship of E93 and pnt during bract formation? My data suggest that
pnt activates E93 expression early in metamorphosis, but that these genes engage in
mutual repression at later stages. The changing roles of these genes should be explored
further by generating ectopic expression and loss of function clones of E93 and pnt.

E. What is the nature of E932 and E933 alleles? My results suggest that E932 and E933
may be mutations in larval-cell specific regulatory sequences of E93. To test this idea,
the changes present in the E932/3 alleles should be determined by a combination of
genetic mapping and DNA sequence analysis.

F. Are alternate E93 transcripts responsible for the larval cell death and imaginal
patterning functions? My work did not resolve the role of the small E93 RNAs detected
by 3' probes.

Further work should be conducted to determine their structure and

expression patterns.

G. What is the role of E93 in patterning other tissues? Much work remains to determine
the role of E93 in patterning tissues other than bracts. Because so much is known about
eye development, the role of E93 in patterning the 2nd and 3rd pigment cells is likely
tractable; a first approach here would be to use existing lacZ markers for specific cell
types to determine which cells in the eye express E93. The role of E93 in wing vein
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formation is likely also tractable, as the wing vein enhancer of dpp has been defined
(Sotillos and de Celis 2006).

E93 is known to be expressed in the heart during

remodeling (Zeitouni et al. 2007), but its role here is unknown. As a first approach, heart
remodeling should be examined in the E93Vno mutants to determine if abnormalities are
present. The different cases of neuronal remodeling should also be examined in E93Vno
mutants.
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Appendix
Stocks used in the experiments
hs-rasV12/CyO perimon
w118; Df(3R) Exel 6188 / TM6B (E93 Df stock)
Tp(3;3)Vno / TM6B
w/+; +; E93Vnol(3)ry93 / TM6B
BL# 10616
UAS-pnt.P1: w[1118]; P{w[+mC] pnt[P1.UAS]=UAS-pnt.P1}3 (BL# 869)
Aos-lacZ: P{ry[+t7.2]=PZ}argos[05845] CG33158[05845] ry[506]/TM3, ry[RK] Sb[1] Ser[1]
(BL# 11674)

y w FLP122; FRT82B CD2 y+ M(3)W Bsb / TM6B
y w FLP122; FRT82 Ubi-GFP83/TM6B
FRT82B sr es E93Vnoe47 ca/TM6B
FRT82 roe pp cu sr pntΔ88/TM6B
FRT82B cu E931/2/3 ca / TM6B ♂
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y w FLP12; Act>y+>Gal4 UAS-GFP
y w FLP12; Act>y+>Gal4 UAS-GFP; tub-Gal80ts E93Df/TM6B
UAS-EcR-RNAi: w[1118]; P{w[+mC]=UAS-EcR-RNAi}97 on 3rd (BL#9326)
UAS-E93-ORF; E93Vnoe47/TM6B

E93 antigen I-III sequence and primers used for amplification
E93 antigen-I
(543..782 Gly47-Ala126)
E93 antigen-I (F)543-558: CCGGAATTCggttccgaggacgagc
E93 antigen-I (B)782-768: CGCAAGCTTGggccgacggtctcca
GGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGC
CAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAA
CACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACA
TCACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTACACCATCAC
CACCGCCAGAACCCATCGATTGGAGACCGTCGGCC
E93 antigen-II
(1257..1604 Ala285-Ala400)
E93 antigen-II (F)1257-1272: CCGGAATTCgcactcaaagatacac
E93 antigen-II (B)1604-1590: CGCAAGCTTGcgcattgctgtccac
GCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCA
GCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGAGC
CTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCT
GAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATC
GGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAG
ATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGAC
TCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCG
E93 Antigen-III
(3399..3779 Asn999-His1125)
E93 antigen-III (F)3399-3414: CCGGAATTCaaccatcggaacaatg
E93 antigen-III (B)3779-3765: CGCAAGCTTGgtgactgctgctgct
AACCATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGA
GCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGG
AGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCA
GCCACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCG
GCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGA
GCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAA
GAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGG
CGGCAGCAGCAGCAGCAGTCAC
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Sequence of E93 UAS constructs
Note: Boxed capital letters are predicated ORF of each construct. Small letters are
flanking sequences that inserted into the vector with the predicated ORF.
UAS-ORF
Primers:
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424)):
caacatgcacatcagcagctatga
#13 E93-clone2-end (4007-4026)(4599-4618, clone2 numbering):tttgtatggtactatcaaaa
Sequence:
caac
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
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AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGG
AACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGT
GGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGG
TAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGT
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CACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCG
GCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGAC
CACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGC
GGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAA
CGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGC
CGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTT
CAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGC
CTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCA
GGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCA
GCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACG
CCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCA
TCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTA
AAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGC
CTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCAC
ATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGC
GGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGC
CGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGC
GGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGC
AGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACAT
CACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGA
TCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAG
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaagccacgttttttgatagtaccatacaaa

UAS-clone2
Primers:
#12 Clone_2(f) (1-20): gca gaa ata caa cgc atc cg
#11 E93 ORF downstream (3988-3969) (4580-4561, clone2 numbering):
gttccccctccctccgccta
Sequence:
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gcagaaatacaacgcatccgatatgcaacggaacgcattttcggacgcggcccgagtcgttccgaggtgtagcgtccgattccg
attcagattcagattccgacgatcgcgtatatcaatcatattaaacaaaaacaacaactgcaacaacaacggctacacttttgttagt
aaatttctgttgaattaaaatacgaaacaaaacatataaaaaagtgcaatccaaaaaaaacaaatattaacgttaaacgaactataa
agcaaaataattaaaaaagtagccattacttttgaattgttttcaaatgcaaaaaagaaaaaggttcgtaagcaacaaaaaaaaagt
taaatgctaaagcattttgataatgcaacatatcaaagagccagaatttaaacacagcaaaaaataaataaaataattaatatacaa
acacgcggggcaactgtcaaaaaatctacaacaacacaaagtgcaactttcaacaacaacaaaataagtgcagcagtacaaca
acaaaaagcattacacaattgaacaaacaacatacaaaaaaaaaatattgccaccaaataaaaaaaaacccgaaagaaaattcg
cgcttcattttcacgcgctgcatataatttactctgtgctccacatatatatatatatatatatataataaataaaaaccaaccaatagcc
caaaaaaaaagaaatgaaaagtccgcatcaacaataaaaatctgcctgcatttttgccttttgtgtgagctgcccaccagaacgag
agaagcacttttattgtatataaaaattatatacatcgccgggaggagctgcagcaacccactccaagccagggttgccacgtcct
gagctgctgtaagctctccgcagcagctgcagcagcatcagcatcgcagcagcatcagcagcagcgcagcaaccgccgcag
catcaatttggcttttgggcagagataatttaagacaaatatatgtgatgct
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
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AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGG
AACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGT
GGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGG
TAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGT
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CACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCG
GCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGAC
CACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGC
GGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAA
CGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGC
CGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTT
CAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGC
CTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCA
GGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCA
GCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACG
CCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCA
TCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTA
AAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGC
CTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCAC
ATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGC
GGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGC
CGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGC
GGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGC
AGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACAT
CACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGA
TCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAG
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaac
UAS-E931Nterm
Primers:
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424) ):
caacatgcacatcagcagctatga
#3.3 stop-CD1 (f): catcggctgctcctagggggtcttcttcac
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering):ttaatttggtgttccccctc
#2.3 CD1-stop(b): gtgaagaagaccccctaggagcagccgatg
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Sequence:
caac
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
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CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGG
AACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGT
GGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGG
TAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGT
CACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCG
GCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGAC
CACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGC
GGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAA
CGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGC
CGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTT
CAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGC
CTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCA
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GGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCA
GCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACG
CCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTAG
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa
UAS-E93Vnoe47Nterm
Primers:
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424) ):
caacatgcacatcagcagctatga
#6.2 stop-e47(f): gctgctcctactcatggtgctggctagccg
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering):ttaatttggtgttccccctc
#5.3 e47-stop(b): gcaccatgagtaggagcagccgatggccgc
Sequence:
caac
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
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AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGTAG
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa
UAS-E93Vnoe47Cterm
Primers:
caac-ATG(after e47 at 1515): CAACatgaaacaccatgacc
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering): ttaatttggtgttccccctc
Sequence:
caac
ATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGAC
TCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGT
ATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGA
GCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAAT
GGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCA
TCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGG
GATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATC
AAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTA
AATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGC
TGCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGC
AGCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGAC
TCCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATA
CTGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGT
CGCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAG
CCTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGG
CAGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCC
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CAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCAT
ACAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGG
CCAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGG
CGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATC
ATTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCC
AACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCT
GAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTA
TCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACG
AACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGC
GGAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACAT
GGTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGA
GGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGG
GCATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTG
AAGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCA
CCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGG
GCAACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCA
GCAGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATT
TGGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATG
GCCAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATT
CCGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAA
ACCACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCA
AGTGCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCA
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CGTCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACC
AGGCGGATCAGTTATAG
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa

UAS-Δpipsq
Primers:
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424) ):
caacatgcacatcagcagctatga
#8.5 flank-pipsq(f): ctggggccagaacatctgttgctgctgttg
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering):ttaatttggtgttccccctc
#7.5 flank-pipsq(b): caacagcagcaacagatgttctggccccag

Sequence:
caac
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
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AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGATGTTCTGGCCCCAGACGAACGCCACGAA
TGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCGGAATCCCCAG
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GCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATGGTGGAGAAC
GTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGC
AGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGGCATGGGCAC
GGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCC
CCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCACCTGTTCGAG
TGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGC
AGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGA
GGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTGGCGCACAA
CAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAA
TGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGA
TGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAAT
GATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAATC
GGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTCCATACTG
CACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAGGCGGATCAG
TTATAG
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa

UAS-LP0 in pUAST (made by Dianne Duncan)
cggttcgcttcggtcccggccccgctgatttggatttggattcggattctcggtttctcggtttctcggcttcacgcttcctcggattct
cggtttctcggatacttggctactccgatagtgggatattctcgccagactcggcttctctgcgagattctccattctcctcactgccc
agacgggcgattcttgtgcccgaccgatttgggttcggatcgaaggcggcgttcgctgctgcagcgtttgccggcgtcgctgcct
gcgctcttgcgtattagtaacgtcgttgacatgccaggccactaaaaacgaaaaaaaaaaataaaaaagtaaaaagagctgaaa
atgcaaaagtgctgtgacaaccacaaataaatgatagaaggaaaaaagtttaatacattaaaaacaaataccacaaacaaagtca
acgttttcatcgtactgcaaaaaaaccacaaattttttacatatttacattaatgagcttgtaaatattgggacgcattgccacgaaaa
gtacagttgcgatctaacaatatcgccaatatatcctcaaaaagaaagct
ATGGCCGATTGTTCATATGTGAGATGTCAGCAAGAGCGTCGGCTCATCAAAA
AGAAGCTATTGAAATGGTCCACAGATATGCTGCATATTGTGGCCCTAGAACG
CGTTGCTGAAGAATGTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAA
CTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCG
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GTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGCC
AGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAAC
ACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACAT
CACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTACACCATCACC
ACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTT
AACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAG
CAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACATTCATCAGCACGA
CAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGC
AGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCA
AGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCT
ACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGATGGACTCGATGG
CCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCG
CTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTA
ACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAG
ATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGCAAACCATC
GCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACG
CCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCC
CTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGC
ACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCA
TGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGA
TGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGA
GTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGC
AGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACAT
CCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGC
TGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCA
ATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGC
TGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTC
CGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAA
CAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAA
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CATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGA
ACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCC
GTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGA
CTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCA
GCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCA
GCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTA
CTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATG
ATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGT
CTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCT
CGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAAC
GGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCAT
TCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGG
AGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATG
ACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGT
CGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTA
CAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCC
GCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGAC
AAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAG
AACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCG
GCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCAC
AGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACGAACGCCACGAA
TGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCGGAATCCCCAG
GCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATGGTGGAGAAC
GTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGC
AGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGGCATGGGCAC
GGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCC
CCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCACCTGTTCGAG
TGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGC
AGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGA
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GGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTGGCGCACAA
CAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAA
TGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGA
TGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAAT
GATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAATC
GGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTCCATACTG
CACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAGGCGGATCAG
TTA
taggagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggag
ggggaacaccaaattaagccacgttttttgatagtaccatacaaatcactaaatagaattatatatatatatatatatatatatatacata
tataataatttatgccagccagctgaccgatgtgcgtggtaaatgtgcgctagctcttagttaaatgtgtaatcaactgcatagggga
aaaacaaaaccacaggaaatcataaacaacaacaaacaaacaaaaaaaaaaaaaaaaaa

UAS-E93 in pUAST (made by Baehrecke)
The pUAST sequence preceding the ORF should be “agatctt” followed by the first
“ATG”. The predicated ORF should start from the first ATG in grey shading, like this:
agatcttATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAA
TGTATG……

However, the red “tAT” mutated into “G” at the beginning of ORF, so the predicated
ORF may start from the next in frame ATG in grey shading, like this:
agatctGGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAAT
GTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCC
ACTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACG
AGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCA
ACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCC
AGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATC
ACGTACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCC
ATCGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGC
TAACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCAC
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TAGTAGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAAC
TCGAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACA
ATAGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAA
CACCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGAC
CCAGCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGC
GCAATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAAC
AGCAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCT
CAGAAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCC
CAGTGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCG
ATTAGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGG
GAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGG
TGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGC
GCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCA
GGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGA
AGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCA
CAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCG
AGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCA
ATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGT
CCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTG
GATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACA
GTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGA
GAACAGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAA
CACCATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCT
ACCGGCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGA
TCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTC
AGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTC
ACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCA
ACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCG
CATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAA
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CAGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAAT
ATCCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGA
AATGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACA
AGAAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACG
GTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACC
TGACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCA
AGGGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTT
TGGTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAG
CGGGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGA
ACGTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTC
GTCGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCG
GGACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATC
AGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGC
CCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTT
CAGCCGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGG
ACTTCAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCA
CGGCCTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCAT
CATCAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAA
TGGCAGCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGG
ACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACC
AACCATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGA
GCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGG
AGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCA
GCCACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCG
GCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGA
GCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGA
AGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATG
GCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCG
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GACATCACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGC
CCAGATCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAG
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaagccacgttttttgatagtaccatacaaatcactaaatagaattatatatatatatatatatatatatatacatatat
aataatttatgccagccagctgaccgatgtgcgtggtaaatgtgcgctagctcttagttaaatgtgtaatcaactgcataggggaaa
aacaaaaccacaggaaatcataaacaacaacaaacaaacaaaaaaaacaaaaataacaagaaccgcaagcaaagaaacata
catttgtgccccggagtgtacgatgtatatttttgtttcgttttgacaatcgacaaataggcattctcttgtacaaactttcttaaaagcta
acaacaaaacaaatctaaaaccttaagaccaaaaaaaacaaaaaatgaaaaaaaa

Probes used in Northern and RPA
E93 unique start (E18set3 clone1.4 pSTBlue1)
Forward primer (17792211-31) ACAAAATAAG TGCAGCAGTA C
Backward primer (17792840-20) CTCGTTAATT ATTTATGACT C
Flanking intron (101)
ACAAAATAA GTGCAGCAGT ACAACAACAA AAAGCATTAC ACAATTGAAC
AAACAACATACAAAAAAAAA ATATTGCCAC CAAATAAAAA AAAACCCGAA
AG
E93 exone aaaattcgcg……tatgaaatat(1-429)
AAAATTCGCGCTTCATTTTCACGCGCTGCATATAATTTACTCTGTGCTCCACA
TATATATATATATATATATATAATAAATAAAAACCAACCAATAGCCCAAAAA
AAAAGAAATGAAAAGTCCGCATCAACAATAAAAATCTGCCTGCATTTTTGCC
TTTTGTGTGAGCTGCCCACCAGAACGAGAGAAGCACTTTTATTGTATATAAAA
ATTATATACATCGCCGGGAGGAGCTGCAGCAACCCACTCCAAGCCAGGGTTG
CCACGTCCTGAGCTGCTGTAAGCTCTCCGCAGCAGCTGCAGCAGCATCAGCA
TCGCAGCAGCATCAGCAGCAGCGCAGCAACCGCCGCAGCATCAATTTGGCTT
TTGGGCAGAGATAATTTAAGACAAATATATGTGATGCTATGCACATCAGCAG
CTATGAAATAT
Flanking intron (99)
GTACGTATGCCAAATTGCTTTTTTTTTCAAATAATCGCAAATAAACTAAAAAT
ATATTTAATGATTAATTGTAATTAAT GAGTCATAAATAATTAACGA
LP0 US (LP08695 unique F made by Dianne)
CGGTTCGCTTCGGTCCCGGCCCCGCTGATTTGGATTTGGATTCGGATTCT
CGGTTTCTCGGTTTCTCGGCTTCACGCTTCCTCGGATTCTCGGTTTCTCG
GATACTTGGCTACTCCGATAGTGGGATATTCTCGCCAGACTCGGCTTCTC
TGCGAGATTCTCCATTCTCCTCACTGCCCAGACGGGCGATTCTTGTGCCC
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GACCGATTTGGGTTCGGATCGAAGGCGGCGTTCGCTGCTGCAGCGTTTGC
CGGCGTCGCTGCCTGCGCTCTTGCGTATTAGTAACGTCGTTGACATGCCA
GGCCACTAAAAACGAAAAAAAAAAATAAAAAAGTAAAAAGAGCTGAAAAT
GCAAAAGTGCTGTGACAACCACAAATAAATGATAGAAGGAAAAAAGTTTA
ATACATTAAAAACAAATACCACAAACAAAGTCAACGTTTTCATCGTACTG
CAAAAAAACCACAAATTTTTTACATATTTACATTAATGAGCTTGTAAATA
TTGGGACGCATTGCCACGAAAAGTACAGTTGCGATCTAACAATATCGCCA
ATATATCCTCAAAAAGAAAGCTATGGCCGATTGTTCATATGTGAGATGTC
AGCAAGAGCGTCGGCTCATCAAAAAGAAGCTATTGAAATGGTCCACAGAT
ATGCTGCATATTGTG

E93 ORF MUS (E93 ORF minus unique start)
CCCTAGAACG……GGCGGATCAG (430-3896=>3467)
CCCTAGAACGCGTTGCTGAA E93NUSI(F)
AAGTGGACCAGGCGGATCAG >> CTGATCCGCCTGGTCCACTT E93NUSII(B)
CCCTAGAACGCGTTGCTGAAGAATGTATGGGTCGCAGGCAATGGAAACATTA
TCAAGACAAACTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGCCCATA
GCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAG
GAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTG
GAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAAC
AACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTA
CACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTGCAA
CTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGG
CCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACATTCA
TCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACATCAGC
AGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCACATT
GCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAACTCCC
TTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGATGGA
CTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGA
TCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATCGCTA
GTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGC
ACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGC
AAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGAGCCT
GTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGA
GCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGC
TAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAGATG
AAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGACTCC
AACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGTATC
CGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGAGCA
CAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAATGGG
GCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCATCC
ATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGGGAT
TGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATCAAG
GGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAAATC
TGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGCTGCA
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ACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGCAGCA
GCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACTCCG
GAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATACTGA
AGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCC
GGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGCCTC
AGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGCAGC
AATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCCAAG
GTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATACAG
AAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGCCAG
GAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGCGGCT
CCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCATTGG
CGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAG
CACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCTGAGCG
CCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTATCGCA
ACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAGAGGTG
AAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCCACGCT
GGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGAGAGCC
CAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGCTGCAG
CTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCAATGCCC
TCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAG
CAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGG
TCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACGAACGCC
ACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCGGAATC
CCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATGGTGGA
GAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAGGGCAA
TGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGGCATGG
GCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAG
ACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCACCTGTTC
GAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTA
TGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGA
TGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTGGCGCAC
AACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACC
AATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCCGAAACG
GATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAA
ATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAAT
CGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTCCATACT
GCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAGGCGGATCA
G
E93 ORF MUSII (E93 ORF minus unique start II)
CAGCAGCAGC……GGCGGATCAG (2171-3896=>1726)
CAGCAGCAGCAGCCTGTCGC E93NUSII(F)
AAGTGGACCAGGCGGATCAG>> CTGATCCGCCTGGTCCACTT E93NUSII(B)
CAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCACCATCCG
CTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCACAGCAGC
AACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCGCCCATGC
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TGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGAC
CTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCAGCGCCAG
ATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGTTAGCGAT
TGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCA
TTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCGGAGCCTC
GCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGACCCACCAG
CAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGA
CCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGTGGAGGCG
GTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACT
ACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGTCACCTGAT
GCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACC
GGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGACCACATGGT
GGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCG
GCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTG
AAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACAT
GTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTTCAATCGC
ATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGCCTGATGA
AGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCAGGAAGA
CGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACG
GTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACGCCCTGCT
CGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCATCGGAAC
AATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGT
CGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGCCTGAGCG
CCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCACATCAACA
ACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCG
GCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGCCGGATGA
CGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAA
GTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGCAGCAGCA
GCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACATCACAGTCC
TGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCC
GAGCAAGTGGACCAGGCGGATCAG
l(3)S12
a 1376 bp MscI-HindIII fragment extending from -1755 to -3131 of rosy gene
(numbering as in Lee et al. 1987,Dutton and Chovnick 1991) is isolated from fly genome
DNA. This fragment contains all of the putative ORFs identified for the l(3)S12 gene
(Dutton and Chovnick 1991), as well as 1155bp of additional 3’ sequence. (Quote from
Horowitz and Berg 1995)
AAGCTTTAAC……CTAGACATGG (-3131- -1755 =>1377bp, but the NCBI sequence
is 1366bp)
AAGCTTTAACTATGTTTAAT (-3131 - -3112) forward primer
CTCGTAACCCCTAGACATGG (-1774 - -1755) >>> CCATGTCTAGGGGTTACGAG
backward primer
AAGCTTTAACTATGTTTAATCTCCCATAGAGCTTCGTTATCTTCGGACGCGAT
GTGGCGCAGATCCCGTGCTTTCGTAACAGTTTTCTCTACGGAATCAGCGGAGG
AATCGGCATCGGCTTGCTGACTTTTCTGGGCACCTCGCGAACCCACCTGTCCA
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CCCACGTGGGCTTCGGCTCCTTCTTCTGCGGCACCATCGCCTACTGGATGACC
TGCAGGTAAGTGACTGTGATTAAAACCGTGCGGCGCCCTTATCACTTAATTAT
CAATGTGGCATCCGCAGGTATCAATGGTCCGTCAGGAGATTCGAGCAGCAGC
AATTGCGTGAGGCGATGAGACGACAAGCCCTTTATGAGGGCACCCAAAGGG
AGAGAGACTTAGATCTGAAGTCGGCGTAGCATAAGTCAGATCCTTCATTACT
ACTTCGATGTTTGTTTTCACTCTAGGATACCAAGTAATCCTGGCATTGTTAAA
TCCCTTGTGTTGTAAACTACCTTTTGTTACCAAACTTTATAGTAGCCAATATAT
TATATATATGTTGTAAGTGAAATCTTAGCTTGCCACTCGTAGGGAATTAATTA
TGCCACCATCTTTGATTTGGGATTGACAGAAATCAATCCATCATTTTAATGAT
TGTGGTTCCTAAAACCTGTTGGGCTTTATTGTGCTTTCGATTTGATTTAAGCTG
ATAGAGCTAGTTGTTTACTTTTGAAGAACCTTGAACCCATTTTGACGACCTTT
TAACTTTTTAATAGTTTTTTTTTACCATTTACATAAAAGCAAAATTTACAGTCT
AAAAGTTGTATATTCAATACGTTCTGGTACGTAAAAGGGTTATTTAATGCACC
ATTTTTACAACTTTAGATAGTATACTTTTTACTTGAGTGGGAGCCATATCACA
AAAATGAAATGAAAGGTTAAAAAAGTATCTAAAAGTAAGTTTCAATTAATAT
TCTGAAAAATAATTGCATTTCATGTACGTTTCTCTGAAATACCCCTAATTCGA
TACTATTTATAAATCTGGAAGATATATAGCTAGGAAATAGATTTATATATTTG
CCTAGTTTGAACACCTTGTGAACATTTTGTTTAAAAAAAAAGCGTATCGTGGT
ACTAGAAAACTTTAAGATACAGATAAATAACTTCACTATACCGAGGTTTTGG
TGTTTCTTGAGACTGAAGGACAATCTTCAAAATGGTCTTAATTCTTGAGATAG
AAAAGCTGCAGTTCTCATGCTGAATAGTGATCAGTACGATTTTATCTGACAGA
TTGCTTTCCTAGCTGACCACACCGATCTCGGATGGGTATCTGCTCTAATCCGA
GATAGCAGGTAGTAGAACTGCTGCCTCGTAACCCCTAGACATGG
E93 pipsqk
TGAGCGCCCA…….TTCAGCCGAA (2653-3097 =>445bp )
TGAGCGCCCAGGAGGCATTG (2653-2672) E93 pipsq(F)
GCGTTATCCTTTCAGCCGAA (30783097) >>> TTCGGCTGAAAGGATAACGC E93 pipsq(B)(3097-3078)
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAGGCGTTATCCTTTCAGCCGAA
E93 AccI
ACCCATGTAA……ATCGAAAATC (6569-8284 => 1716 bp)
ACCCATGTAAAGAAATTGTA (6569-6588) E93AccI(F)Forward primer
TACCGTATGGATCGAAAATC (8265-8284) >>> GATTTTCGATCCATACGGTA
E93AccI(B) Backward primer
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ACCCATGTAAAGAAATTGTAGACAGATCGGATAAAACGAAACTAAACCAAG
CACAAGCTAATGGCCCAAATGCAGTTGGCCCCGAAAATCGAGCGCTGCATTT
GGCCAAGAGAATTTCTTAAGCTACGGCACACATCACTGAAAACAAAAACTGA
AAACTGAATACTGAATACTGAGAATAGGAAACAGTAAGCAGAAGACAAGAT
CGATGGTACTGTTCAGAACATATATAGTTGTATATATTTTGGAATAATGTTTA
CCAGTTCAAGTCAAAATTAAAAGGAAAAAAAAATGCAGTCTTTTATAATGCA
AAATTATACAAAGAAAAATTACAATTTCGCAACGCTAAAAAATGAAAAACG
AAAATATTGATGTAAAAAGAATGAAAATCAAACTTAAAATAATAAACAAGA
TAAAGTGCAATTATACGGTTTAAATAAGCAAATTTAAGAAACAAACGTTATA
AACAAAAACACAAACATGTTAAAACAATGAAAATATTTCGAAGCAAGTTTAG
CTACAAATTCCAAGGCAACTGATAATGACAAGAACCATTTACAAGAAAACCC
AAGACAGCAAAGTACAGTGCGTTTCATAACCCGCAATACGGGCAATCGAATA
CTACCATTCCATTGCCCATGGAGAACTGAAACGCACTTTGGCCCTACTTCATA
TTGATAGGGTAATCGGATCCAAAATCTGTAAACCAAATTTTGGGATCAGCGA
TTAAAACCTTAACGGAAGTTCATAACTGCAGAAAAAAAAAGTCGAAAGTCGA
AATGTCAACCTAGTGGTAGTTCGAAACACAAAAACAAAATAAACCAATCGAG
TGTAATTGAGTGACAGCTTGAGAATGTTGAATTGTATAGAATTTTTGCTTGTG
CACCTGGTCGAGGGGGGCGTGGTTGCGCCCCCTTTTTGGTTTCTAGGTGAACA
GGCGAAAACGCTCAGGTACGTGTTTTATTTTTCGGAGAGAAACAAGATTGAT
TACCCATACATTACTTATTCTTTGTTTTACTACAACATAATAGTTAATATTTGT
ATAAAAAAAAAAGACGACGATGGCGAGAAGGGAAAACCAGCTAAAAAAATT
GATATATTCATAATATAGAATTGTTTTAAATGGTTTGAGAGCGAAAAATATTG
AGGGTTTCTAGCGTGCTTCATGAAATTGCTCATATTTGTGTATAAAACCTTAT
TTGTTCAATGCGAATCAAAATTTGCTGAATATAAGTGCATATATATATAATTA
GAGTTTATTTTTCGGTTTAGTTAAGCGCATAAAATGATTACGATTTAAATAAT
TATTATTAGTTATGACCTAATAGTAGGCAAATCAAAATTTCTTCACATAAAAC
AATCAACTTCTACTTTCAAATAATTTCTAGACGTATGTAACTATAGTTATTATT
CTATTATTATACGGACTAAAACTATTTAGCGCGTTGTTAGACTCGATTTATGG
TTTGTACATATTAGACAACATTTTTATGGTATTCTCCTCTTTTTTTATTATTACT
AGCATTATTACTCCCTATTTTAATTGACTTCTTAAATGGGCAACATCATTTTGA
ACTATAGTGCAATTGTTTCAAACAAAACCAAGCAACCAACAACAAATATATT
AACATTAAAGATTAATATAATTTACAAGCTTTCTTTGCCGATGCCAAGAAGG
ATGAATAACGCATATGTCTACCGTATGGATCGAAAATC
E93 5exoI
E93exo5-1(f)(1372-1391): CCACGCCGTCGGGAAGAAGG
E93exo5-1(b)(1944-1922): Acugcuaaaucugcuguccgcca >>>>
TGGCGGACAGCAGATTTAGCAGT
CCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCC
TACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCA
CCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCAT
GACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGAT
GCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGT
TTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAG
CGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCG
GCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGG
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ATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATG
CCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGG
TGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGC
CA
E93 5exoII
E93exo5-2(f)(2037-2056):Cagcaacatgtcgccgccta
E93exo5-2(b)(2652-2633):Ccagcaacagcagcaacagc >>>> gctgttgctgctgttgctgg
CAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACTCCGG
AAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATACTGAA
GATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCG
GGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGCCTCA
GCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGCAGCA
ATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGG
TGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATACAGA
AGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGCCAGG
AGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGCGGCTC
CTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCATTGGC
GGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAGC
ACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGC
E93 5exoIII
E93exo5-3(f)(3098-3117):Catgttctggccccagacga
E93exo5-3(b)(3899-3880):Tggaccaggcggatcagtta >>> taactgatccgcctggtcca
CATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTTCAAT
CGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGCCTGA
TGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCAGGA
AGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCAGCA
ACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACGCCC
TGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCATCG
GAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTAAA
GCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGCCTG
AGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCACATC
AACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGCGGC
GGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGCCGG
ATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGCGGCG
AAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGCAGCA
GCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACATCACA
GTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGATCAA
GGCCGAGCAAGTGGACCAGGCGGATCAGTTA
E93 234exo
CCCTAGAACGCGTTGCTGAA E93_234exo(F)(430-449)
GGCGATGTGAAGTCCGTCAG>>>> CTGACGGACTTCACATCGCC
E93_234exo(B)(1357-1338)
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CCCTAGAACGCGTTGCTGAAGAATGTATGGGTCGCAGGCAATGGAAACATTA
TCAAGACAAACTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGCCCATA
GCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAG
GAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTG
GAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAAC
AACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTA
CACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTGCAA
CTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGG
CCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACATTCA
TCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACATCAGC
AGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCACATT
GCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAACTCCC
TTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGATGGA
CTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGA
TCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATCGCTA
GTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGC
ACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGC
AAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAG
E93 5exo boundary
tatattttaggggaaatccg E93 5exo intron (f) (17829412-17829431)(successful)
GCTGAGGCGGAAGTGGACAG (1578-1597)>>> CTGTCCACTTCCGCCTCAGC
E93 5exo exon II(b)(1597-1578)
tatattttag gggaaatccg aaacgaattg acagaaatat acaatcttat cacaacacct gagtgagtgg
TTGTAAAGCA GAATATGACT TTTACGAACT CGCAATAAAC CAATCATCAT
GAGCTTTAAC AGATATTACG AAATATAACC AGTGTAGGTT TATTATTTAC
CTATATATAC AGGTATACAT TAGACTTTTA GAAGTTTGTG CTCCTTAAAA
ACTTTTGGAT TGTCACTATA AACTTAATTT GTTTCCGTTA TCCCTTGCAG
AGCCTGTGCC ACGCCCACGC CGTCGGGAAG AAGGGCGTAC AGTGAAGAGG
aTCTGAGCCG GGCCCTACAG GATGTGGTGG CCAACAAGCT AGATGCCCGG
AAATCGGCTA GCCAGCACCA TGAGCAGCGC TCCATTCTGG ACAACCGGCT
GTTCAAGATG AAACACCATG ACCAGGAGCA GGATCATGAT GGCGACGAGC
TCGAGGACTC CAACGATGAT GCTGAGGCGG AAGTGGACAG
clone2-unique start
Clone_2(f) (1-20) forward primer to make clone_2 unique start: gca gaa ata caa cgc atc
cg
Clone_2(b) (592-573) reverse primer to make clone_2 unique start: ctt tcg ggt ttt ttt tta tt
GCAGAAATACAACGCATCCGATATGCAACGGAACGCATTTTCGGACGCGGCC
CGAGTCGTTCCGAGGTGTAGCGTCCGATTCCGATTCAGATTCAGATTCCGACG
ATCGCGTATATCAATCaTATTAAACAAAAACAACAACTGCAACAACAACGGC
TACACTTTTGTTAGTAAATTTCTGTTGAATTAAAATACGAAACAAAACATATA
AAAAAGTGCAATCCAAAAAAAACAAATATTAACGTTAAACGAACTATAAAG
CAAAATAATTAAAAAAGTAGCCATTACTTTTGAATTGTTTTCAAATGCAAAA
AAGAAAAAGGTTCGTAAGCAACAAAAAAAAAGTTAAATGCTAAAGCATTTT
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GATAATGCAACATATCAAAGAGCCAGAATTTAAACACAGCAAAAAATAAAT
AAAATAATTAATATACAAACACGCGGGGCAACTGTCAAAAAATCTACAACAA
CACAAAGTGCAACTTTCAACAACAACAAAATAAGTGCAGCAGTACAACAAC
AAAAAGCATTACACAATTGAACAAACAACATACAAAAAAAAAATATTGCCA
CCAAATAAAAAAAAACCCGAAAG
1st half pipsq (P1)
TGAGCGCCCAGGAGGCATTG E93 pipsq(F) (2653-2672)
Gagcccaagccgcagcccga >>> tcgggctgcggcttgggctC E93 pipsq_II(b)(2878-2859)
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGA
2nd half pipsq (P2)
Tctcgtcggcctgaccggac E93 pipsq_II(f)(2879-2898)
GCGTTATCCTTTCAGCCGAA (30783097) >>> TTCGGCTGAAAGGATAACGC E93 pipsq(B)(3097-3078)
TCTCGTCGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAG
GCGGGACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAAC
AATCAGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCC
ACGCCCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTAT
CCTTTCAGCCGAA
Primers for RTPCR
Primer #1: E93 3rd common exon (E93_3_com_exo(b)) (1357-1338) first strand primer
for RT-PCR
GGCGATGTGAAGTCCGTCAG >>>> CTGACGGACTTCACATCGCC
Primer #2: E93 3rd common exon internal (E93_3_com_exo_int(b)) (1323-1304)
backward PCR primer for RT-PCR
TAGCAGCAAACCATCGCCGA >>>> TCGGCGATGGTTTGCTGCTA
Primer #3: LP0 unique start primer (LP0_US(f)) (576-596) forward PCR primer or RTPCR
GCCGATTGTTCATATGTGAG
Primer #3: E93 unique start primer (E93_US(f)) (408-428) forward PCR primer for RTPCR
CACATCAGCAGCTATGAAAT

Clones from cDNA screening
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Clone1 (LP library F111 pBluescript SK-)
AATGAAAAGTCCGCATCAACAATAAAAATCTGCCTGCATTTTTGCCTTTTGTG
TGAGCTGCCCACCAGAACGAGAGAAGCACTTTTATTGTATATAAAAATTATA
TACATCGCCGGGAGGAGCTGCAGCAACCCACTCCAAGCCAGGGTTGCCACGT
CCTGAGCTGCTGTAAGCTCTCCGCAGCAGCTGCAGCAGCATCAGCATCGCAG
CAGCATCAGCAGCAGCGCAGCAACCGCCGCAGCATCAATTTGGCTTTTGGGC
AGAGATAATTTAAGACAAATATATGTGATGCTATGCACATCAGCAGCTATGA
AATATCCCTAGAACGCGTTGCTGAAGAATGTATGGGTCGCAGGCAATGGAAA
CATTATCAAGACAAACTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGC
CCATAGCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAG
CAAGGAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCG
TCTGGAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGA
GAACAACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACC
AGTACACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGT
GCAACTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTT
GGTGGCCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCAC
ATTCATCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACA
TCAGCAGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCC
ACATTGCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAA
CTCCCTTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCG
ATGGACTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCA
ATCTGATCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGAT
CGCTAGTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGT
CCCGCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTA
GCAGCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAG
AGCCTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGA
TCTGAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAA
TCGGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCA
AGATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGG
ACTCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGT
GTATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCC
GAGCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAA
ATGGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGC
CATCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCT
GGGATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTA
TCAAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCT
AAATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTG
CTGCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAG
CAGCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGA
CTCCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCAT
ACTGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTG
TCGCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACA
GCCTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACG
GCAGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGC
CCAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCA
TACAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTG
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GCCAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATG
GCGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGAT
CATTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCC
CAACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGC
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACG
AACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGC
GGAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACAT
GGTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGA
GGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGG
GCATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTG
AAGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCA
CCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGG
CAACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAG
CAGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTT
GGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGG
CCAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTC
CGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAA
CCACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAA
GTGCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACG
TCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAG
GCGGATCAGTTATAGGAGCAGCCGATGGCCGCGAATCCAGCGTTCGCCTGGC
CACCGCTGGCCGCCCACTACTACAGCTTCTAGGCGGAGGGAGGGGGAACACC
AAATTAAGCCACGTTTTTTGATAGTACCATACAAATCACTAAATAGAATTATA
TATATATATATATATATATATATACATATATAATAATTTATGCCAGCCAGCTG
ACCGATGTGCGTGGTAAATGTGCGCTAGCTCTTAGTTAAATGTGTAATCAACT
GCATAGGGGAAAAACAAAACCACAGGAAATCATAAACAACAACAAACAAAC
AAAAAAAACAAAAA
Clone2 (LP library F211 pBluescript SK-)
GCAGAAATACAACGCATCCGATATGCAACGGAACGCATTTTCGGACGCGGCC
CGAGTCGTTCCGAGGTGTAGCGTCCGATTCCGATTCAGATTCAGATTCCGACG
ATCGCGTATATCAATCATATTAAACAAAAACAACAACTGCAACAACAACGGC
TACACTTTTGTTAGTAAATTTCTGTTGAATTAAAATACGAAACAAAACATATA
AAAAAGTGCAATCCAAAAAAAACAAATATTAACGTTAAACGAACTATAAAG
CAAAATAATTAAAAAAGTAGCCATTACTTTTGAATTGTTTTCAAATGCAAAA
AAGAAAAAGGTTCGTAAGCAACAAAAAAAAAGTTAAATGCTAAAGCATTTT
GATAATGCAACATATCAAAGAGCCAGAATTTAAACACAGCAAAAAATAAAT
AAAATAATTAATATACAAACACGCGGGGCAACTGTCAAAAAATCTACAACAA

136

CACAAAGTGCAACTTTCAACAACAACAAAATAAGTGCAGCAGTACAACAAC
AAAAAGCATTACACAATTGAACAAACAACATACAAAAAAAAAATATTGCCA
CCAAATAAAAAAAAACCCGAAAGAAAATTCGCGCTTCATTTTCACGCGCTGC
ATATAATTTACTCTGTGCTCCACATATATATATATATATATATATAATAAATA
AAAACCAACCAATAGCCCAAAAAAAAAGAAATGAAAAGTCCGCATCAACAA
TAAAAATCTGCCTGCATTTTTGCCTTTTGTGTGAGCTGCCCACCAGAACGAGA
GAAGCACTTTTATTGTATATAAAAATTATATACATCGCCGGGAGGAGCTGCA
GCAACCCACTCCAAGCCAGGGTTGCCACGTCCTGAGCTGCTGTAAGCTCTCC
GCAGCAGCTGCAGCAGCATCAGCATCGCAGCAGCATCAGCAGCAGCGCAGC
AACCGCCGCAGCATCAATTTGGCTTTTGGGCAGAGATAATTTAAGACAAATA
TATGTGATGCTATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCT
GAAGAATGTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGT
GCAGCCACTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGA
GGACGAGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAA
TCCCAACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGG
CAGCCAGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGAT
TCATCACGTACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAG
AACCCATCGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCG
CCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACT
GCCACTAGTAGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACA
GCAACTCGAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAA
CAACAATAGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAG
AGCAACACCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTG
CTGACCCAGCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGC
TGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGC
CAACAGCAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACT
ACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCA
GTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTC
ATCGATTAGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCG
TCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGAT
GTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGC
AGCGCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGA
GCAGGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCG
GAAGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGG
CACAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGG
CGAGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGC
AATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATG
TCCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTG
GATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACA
GTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGA
GAACAGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAA
CACCATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCT
ACCGGCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGA
TCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTC
AGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTC
ACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCA
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ACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGC
ATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAAC
AGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATAT
CCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAA
TGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAG
AAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGT
TCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTG
ACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAG
GGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTG
GTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCG
GGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAAC
GTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGT
CGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGG
ACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAG
GCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCC
AACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCA
GCCGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGAC
TTCAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACG
GCCTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCAT
CAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGG
CAGCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACA
CGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAAC
CATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCG
TAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGC
GCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCC
ACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCG
GCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCA
GCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAG
CGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGG
CAGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACA
TCACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAG
ATCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAGGAGCAGCCGATG
GCCGCGAATCCAGCGTTCGCCTGGCCACCGCTGGCCGCCCACTACTACAGCT
TCTAGGCGGAGGGAGGGGGAACACCAAATTAAGCCACGTTTTTTGATAGTAC
CATACAAA
Clone3 (LP library F311 pBluescript SK-)
TCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTC
AGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTC
ACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCA
ACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGC
ATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAAC
AGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATAT
CCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAA
TGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAG
AAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGT

138

TCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTG
ACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAG
GGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTG
GTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCG
GGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAAC
GTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGT
CGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGG
ACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAG
GCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCC
AACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCA
GCCGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGAC
TTCAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACG
GCCTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCAT
CAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGG
CAGCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACA
CGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAAC
CATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCG
TAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGC
GCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCC
ACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCG
GCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCA
GCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAG
CGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGG
CAGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACA
TCACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAG
ATCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAGGAGCAGCCGATG
GCCGCGAATCCAGCGTTCGCCTGGCCACCGCTGGCCGCCCACTACTACAGCT
TCTAGGCGGAGGGAGGGGGAACACCAAATTAAGCCACGTTTTTTGATAGTAC
CATACAAATCACTAAATAGAATTATATATATATATATATATATATATATACAT
ATATAATAATTTATGCCAGCCAGCTGACCGATGTGCGTGGTAAATGTGCGCT
AGCTCTTAGTTAAATGTGTAATCAACTGCATAGGGGAAAAACAAAACCACAG
GAAATCATAAACAACAACAAACAAACAAAAAAAACAAAAA
Clone5 (LP library F511 pBluescript SK-)
CCCGCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTA
GCAGCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAG
AGCCTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGA
TCTGAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAA
TCGGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCA
AGATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGG
ACTCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGT
GTATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCC
GAGCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAA
ATGGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGC
CATCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCT
GGGATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTA
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TCAAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCT
AAATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTG
CTGCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAG
CAGCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGA
CTCCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCAT
ACTGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTG
TCGCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACA
GCCTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACG
GCAGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGC
CCAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCA
TACAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTG
GCCAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATG
GCGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGAT
CATTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCC
CAACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGC
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACG
AACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGC
GGAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACAT
GGTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGA
GGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGG
GCATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTG
AAGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCA
CCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGG
CAACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAG
CAGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTT
GGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGG
CCAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTC
CGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAA
CCACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAA
GTGCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACG
TCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAG
GCGGATCAGTTATAGGAGCAGCCGATGGCCGCGAATCCAGCGTTCGCCTGGC
CACCGCTGGCCGCCCACTACTACAGCTTCTAGGCGGAGGGAGGGGGAACACC
AAATTAAGCCACGTTTTTTGATAGTACCATACAAATCACTAAATAGAATTATA
TATATATATATATATATATATATACATATATAATAATTTATGCCAGCCAGCTG
ACCGATGTGCGTGGTAAATGTGCGCTAGCTCTTAGTTAAATGTGTAATCAACT
GCATAGGGGAAAAACAAAACCACAGGAAATCATAAACAACAACAAACAAAC
AAAAAAAACAAAA
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Clone6 (LP library F611 pBluescript SK-)
ATAGCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGC
AAGGAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGT
CTGGAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAG
AACAACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACCA
GTACACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTG
CAACTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTG
GTGGCCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACA
TTCATCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACAT
CAGCAGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCA
CATTGCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAAC
TCCCTTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGA
TGGACTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAAT
CTGATCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATC
GCTAGTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTC
CCGCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAG
CAGCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGA
GCCTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGAT
CTGAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAAT
CGGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAA
GATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGA
CTCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTG
TATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCG
AGCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAAT
GGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCA
TCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGG
GATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATC
AAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAA
ATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGCT
GCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGCA
GCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACT
CCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATAC
TGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTC
GCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGC
CTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGC
AGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCC
AAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATA
CAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGC
CAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGC
GGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCA
TTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCA
ACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCTG
AGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTAT
CGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAGA
GGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCCA
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CGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGAG
AGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGCT
GCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCAA
TGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAGC
AGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGAG
GCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACGA
ACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCG
GAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATG
GTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAG
GGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGG
CATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGA
AGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCAC
CTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGC
AACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGC
AGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTG
GCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGC
CAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCC
GAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAAC
CACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGT
GCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTC
CATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAGGC
GGATCAGTTATAGGAGCAGCCGATGGCCGCGAATCCAGCGTTCGCCTGGCCA
CCGCTGGCCGCCCACTACTACAGCTTCTAGGCGGAGGGAGGGGGAACACCAA
ATTAAGCCACGTTTTTTGATAGTACCATACAAATCACTAAATAGAATTATATA
TATATATATATATATATATATACATATATAATAATTTATGCCAGCCAGCTGAC
CGATGTGCGTGGTAAATGTGCGCTAGCTCTTAGTTAAATGTGTAATCAACTGC
ATAGGGGAAAAACAAAACCACAGGAAATCATAAACAACAACAAACAAACAA
AAAAAACAAAAA
Clone7 (LP library F711 pBluescript SK-)
TGCAGCAGCATCAGCATCGCAGCAGCATCAGCAGCAGCGCAGCAACCGCCG
CAGCATCAATTTGGCTTTTGGGCAGAGATAATTTAAGACAAATATATGTGAT
GCTATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAAT
GTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCA
CTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAG
CCATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAAC
CACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAG
CTATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCAC
GTACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCAT
CGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTA
ACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTA
GTAGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTC
GAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAAT
AGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACA
CCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCC
AGCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGC
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AATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAG
CAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGGA
TGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGCC
AGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTGC
TGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATGA
AACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGGT
GGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAACA
GCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACCA
TCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCGG
CATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCGA
ACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCGG
TCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCAC
CATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCAC
AGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCGC
CCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTTT
GCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCAG
CGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGTT
AGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAGC
CGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCGG
AGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGACCC
ACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGGAA
CGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGTGGA
GGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGGTAG
CTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGTCAC
CTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCGGCC
TGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGACCAC
ATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGCGGC
TGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAACGG
CCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGCCGA
ACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTTCAA
TCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGCCTG
ATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCAGG
AAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCAGC
AACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACGCC
CTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCATC
GGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTAA
AGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGCCT
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GAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCACAT
CAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGCGG
CGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGCCG
GATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGCGGC
GAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGCAGC
AGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACATCAC
AGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGATCA
AGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAGGAGCAGCCGATGGCCG
CGAATCCAGCGTTCGCCTGGCCACCGCTGGCCGCCCACTACTACAGCTTCTAG
GCGGAGGGAGGGGGAACACCAAATTAAGCCACGTTTTTTGATAGTACCATAC
AAATCACTAAATAGAATTATATATATATATATATATATATATATACATATATA
ATAATTTATGCCAGCCAGCTGACCGATGTGCGTGGTAAATGTGCGCTAGCTCT
TAGTTAAATGTGTAATCAACTGCATAGGGGAAAAACAAAACCACAGGAAATC
ATAAACAACAACAAACAAACAAAAAAAACAAAAA

Bacterial stocks

Box #
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8

Slot
#
6E
7E
8E
1F
2F
3F
4F
5F
6F
7F
8F
1G
2G
3G
4G
7G
8G

Exp#
1
1
1
1
1
2
2
2
2
2
5
5
5
5
7

8 2H
8
9
9
9

3H
1A
2A
3A

11
11
11

Name
E18set1 clone1.3 pSTBlue1
E47aset clone2.2 pSTBlue1
E18set2 clone4.2 pSTBlue1
E47aset2 clone5.5 pSTBlue1
E31set2 clone6.5 pSTBlue1
E18set3 clone1.4 pSTBlue1 / E93
unique start
E47aset3 clone2.2 pSTBlue1
E31set3 clone3.4 pSTBlue1
E18set4 clone4.1 pSTBlue1
E47aset4 clone5.2 pSTBlue1
E31set1 clone7 pSTBlue1
E18cg31353 clone2 pSTBlue1
E47 cg31353 clone4 pSTBlue1
E31 cg31353 clone5 pSTBlue1
E31set4 clone31.4.1 pSTBlue1
LP08695 pOT2
LP08695 unique F pSTBlue
LP0-UAST in DH5a bacteria
strain
LP0-UAST in XL1Blue bacteria
strain
E93 2/18-4 pBS
E93 rp-2 pBS
E93 2/1 rp5 pBS
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Date
9/8/2004
9/8/2004
9/8/2004
9/8/2004
9/8/2004

Antibiotics
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan

Origin
Joanna
Joanna
Joanna
Joanna
Joanna

9/22/2004
9/22/2004
9/22/2004
9/22/2004
9/22/2004
9/29/2004
9/29/2004
9/29/2004
9/29/2004
10/19/2004

Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Cmp

Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Flybase
DMD

Amp

DMD

Amp
8/6/2005 Amp
8/6/2005 Amp
8/6/2005 Amp

DMD
Eric
Eric
Eric

1/6/2005

9
9
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna

4A
5A
1A
1B
1C
1D
1E
1F
1G
1H
2A
2B

11
11
31
31
37
37
29
67
67
67
67
81

E93 ORF pBluescript II SK+
pUAST E93
E93 ORF NUS-pSTBlue1
E93 ORF NUSII-pSTBlue1
l(3)S12 pSTBlue1
E93 pipsqk pSTBlue1
E93 AccI 6569-8284 pSTBlue1
E93 5exoII pSTBlue1
E93 5exoIII forward pSTBlue1
E93 234exo pSTBlue1
E93 5exoI pSTBlue1
E93 5exoIII backward pSTBlue1

8/7/2005
8/6/2005
3/4/2006
3/4/2006
4/20/2006
4/20/2006
2/17/2006
7/14/2006
7/14/2006
7/14/2006
7/14/2006
10/2/2006

Joanna 2C

85

10/5/2006 Amp, Tet

Joanna 2D

82

10/6/2006 Amp

Joanna

Joanna 2E

82

10/6/2006 Amp

Joanna

Joanna 2F

82

10/6/2006 Amp

Joanna

Joanna 2G

82

10/6/2006 Amp

Joanna

Joanna 2H

82

10/6/2006 Amp

Joanna

Joanna 3A
Joanna 3B

82
88

Joanna
Joanna
Joanna
Joanna
Joanna

3C
3D
3E
3F
3G

122
136
143
145-42
144-34

Joanna
Joanna
Joanna
Joanna

3H
4A
4B
4C

Joanna
Joanna
Joanna
Joanna

4D
4E
4F
4G

144-86
150-6
151-10
152-7
144131
156-7
143-71
165-7

rp49 pBR322(?)
LP library F111 pBluescript SKin SOLR bacteria strain
LP library F211 pBluescript SKin SOLR bacteria strain
LP library F311 pBluescript SKin SOLR bacteria strain
LP library F511 pBluescript SKin SOLR bacteria strain
LP library F611 pBluescript SKin SOLR bacteria strain
LP library F711 pBluescript SKin SOLR bacteria strain
E93 5exo boundary pSTBlue1
clone2-unique start pSTBlue1
forward
LP0_XhoI-pUAST
E93 clone2-pCR8/GW/TOPO
E93-ORF-pCR8/GW/TOPO
E93-ORF-e47-pCR8/GW/TOPO
E93-ORF-CD1pCR8/GW/TOPO
E93-ORF-pTW
E93-ORF-e47-pTW
E93-ORF-CD1-pTW
E93-ORF-ΔpippCR8/GW/TOPO
E93-ORF-Δpip-pTW
E93-clone2-pCR8/GW/TOPO
E93-clone2-pTW
E93-no-e47-ORFpCR8/GW/TOPO

Eric
Eric
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Joanna
Karmella
Haynes

Joanna 4H

187-8
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Amp
Amp
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan
Amp, Kan

10/6/2006 Amp
Joanna
11/1/2006 Amp, Kan Joanna
6/7/2007
6/7/2007
9/1/2007
10/18/2007
10/23/2007

Amp, Kan
Amp
Spec
Spec
Spec

Joanna
Joanna
Joanna
Joanna
Joanna

11/11/2007
12/9/2007
12/9/2007
12/9/2007

Spec
Amp
Amp
Amp

Joanna
Joanna
Joanna
Joanna

12/16/2007
1/1/2008
1/1/2008
1/3/2008

Spec
Amp
Spec
Amp

Joanna
Joanna
Joanna
Joanna

Apr-08 Spec

Joanna

Joanna
Joanna
Joanna
Joanna
Joanna
Joanna

5A
5B
5C
5D
5E
5F

186-24
186-24
186-25
186-25
186-22
188-35

E93-antigen-I-pET28a #B
E93-antigen-I-pET28a #C
E93-antigen-II-pET28a #B
E93-antigen-II-pET28a #C
E93-antigen-III-pET28a #A
E93-no-e47-ORF-pTW

5/25/2008
5/25/2008
5/25/2008
5/25/2008
5/25/2008
5/28/2008

Kan
Kan
Kan
Kan
Kan
Amp

Joanna
Joanna
Joanna
Joanna
Joanna
Joanna

The Rabbit and Mouse antisera harvested from each bleeding:

pre-immune
1st bleeding
2nd bleeding
(1/16/2009)
3rd bleeding
(2/18/2009)
4th bleeding
(3/17/2009)
5th bleeding
(4/16/2009)
6th bleeding
(5/18/2009)

Rabbit A
volume
4.5ml (900ul*5)
0.9ml (100ul*9)
2.45ml
(1.2ml*2+50ul)

box #
Rab 2nd
Rab small
Rab small

45ml (1ml*45)
1.8ml (100ul*18)
44.1ml (900ul*49)
0.9ml (100ul*9)
45ml (900ul*50)
3.6ml (900ul*4)
50ml (1ml*50)
4ml (1ml*4)
50.4ml (900ul*56)
0.9ml (900ul*1)

Rab 2nd
Rab small
Rab 3rd
Rab small
Rab 4th
Rab small
Rab 5th
Rab small
Rab 6th
Rab small

Rabbit B
volume
5.4ml (900ul*6)
0.9ml (100ul*9)
3.9ml
(1.2ml*2+0.5ml+
0.4ml+0.2ml+100ul*4)
33ml (1ml*33)
0.9ml (100ul*9)
39.6ml (900ul*44)
0.8ml (100ul*8)
45ml (900ul*50)
500ul
50ml (1ml*50)
5ml (1ml*5)
39.6ml (900ul*44)
0.9ml (900ul*1)

Box: Mou small Mouse
#1
pre-immune
200ul
st
1 bleeding
100ul
2nd bleeding
40ul
rd
3 bleeding
400ul

Mouse
#2
200ul
120ul
200ul
400ul

Mouse
#3
400ul
100ul
200ul
400ul

Mouse
#4
400ul
20ul
200ul
400ul

4th bleeding
5th bleeding
6th bleeding

300ul
220ul
320ul

300ul
240ul
320ul

200ul
500ul
660ul

300ul
260ul
500ul
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Mouse
#5
300ul
20ul
400ul
300ul +
10ul*4
200ul
240ul
720ul

box #
Rab 2nd
Rab small
Rab small
Rab 2nd
Rab small
Rab 3rd
Rab small
Rab 4th
Rab small
Rab 5th
Rab small
Rab 6th
Rab small

Mouse #6
500ul
100ul
150ul
250ul +
10ul*5
300ul
900ul
720ul

The bleeding tests from Rabbit and Mouse antisera:
Bleedings
Rabbit A

Rabbit B

Mouse 1
Mouse 2
Mouse 3

Mouse 4

Mouse 5

Mouse 6

Exp. 248
Exp. 272
Exp. 284
Exp. 301
Exp. 248
Exp. 272
Exp. 284
Exp. 301
Exp. 235
Exp. 248
Exp. 235
Exp. 248
Exp. 235
Exp. 248
Exp. 282
Exp. 235
Exp. 248
Exp. 282
Exp. 235
Exp. 248
Exp. 282
Exp. 235
Exp. 248
Exp. 282

preim
-

1st
-

-

+ weak
+

-

-

+
+ strong
+
+
+

-

2nd
+
+
+ weak

3rd

4th

5th

6th

+ weak
+ weak

+ weak
-

+ weak

+
+

+
+
+
+
+
+
+
+

+
+

+

-

-

+
+

+

+
+

+

Exp. 235: surf western blot
Exp. 248: 2hr AP midgut tissue staining
Exp. 272: en-Gal4>UAS-LP0 embryo stripes
Exp. 282: en-Gal4>UAS-LP0 embryo stripes
Exp. 284: en-Gal4>UAS-LP0 embryo stripes and WT anterior gut cell
Exp. 301: en-Gal4>UAS-LP0 embryo stripes
Note: The Rabbit B 1st bleeding generated the strongest immune response in all rabbit
sera, and I used it for most of my experiments. However, I found the 1st bleeding of
Rabbit B was mislabeled, and it probably came from Rabbit A. But it was too late to
change all my notes and labels on the eppendorf tubes. To be consistent, I call Rabbit B
as the rabbit who produced the strongest immune response, and Rabbit A as the rabbit
who didn’t respond well. Although the Rabbit got a little bit better in its 6th bleeding, it is
still weaker than the weakest bleeding from Rabbit B (Rabbit 6th bleeding).

147

